AU782483B2 - Stress-resistant oversized transgenic plants capable of growing in salinized soil - Google Patents

Description

1 STRESS-RESISTANT OVERSIZED TRANSGENIC PLANTS CAPABLE OF GROWING IN SALINIZED SOIL BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to genetically-altered plants that are hardy with respect to environmental stresses, such as drought and/or freezing, oversized with o o *o A59587lspeci WO 01/33945 PCT/US00/30955 2 respect to vegetative and/or sexual structure (as compared to their normal phenotypic counterparts), and capable of growing in media of high salinity.

2. Background of the Related Art The prospects for feeding humanity as we enter the new millennium are formidable. Given the every increasing world population, it remains a major goal of agricultural research to improve crop yield. It also is a major goal of horticultural research to develop non-crop plants which are hardier, such as ornamental plants, grasses, shrubs, and other plants found useful or pleasing to man.

Until recently crop and horticultural improvements depended on selective breeding of plants having desirable characteristics. Such selective breeding techniques, however, were often less than desirable as many plants have within them heterogenous genetic complements that do not result in identical desirable traits of their parents.

Advances in molecular biology have allowed mankind to manipulate the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has led to the development of plants with increased pest resistance, plants that are capable of expressing pharmaceuticals and other chemicals, and plants that express beneficial traits.

Advantageously such plants not only contain a gene of interest, but remain fertile.

One particular area of interest of late in plant sciences has been the development.of plants with improved stress resistance. In general, plants possess and maintain adaptive mechanisms to ensure survival during periods of adverse environmental conditions. Two commons stresses that plants commonly encounter are freezing and drought, both of which are associated with cellular dehydration. It is known that certain plants contain genes turned on by exposure to cold or prolonged periods of dehydration that encode for products that are directly or indirectly responsible for providing greater resistance to drought and/or freeze than many of their counterparts. A number of genes responsive to heat and water stress have now been characterized (See, U.S. Pat. Nos.

5,837,545, 5,071,962, 4,707,359). These genes are believed by many to produce certain proteins, such as "Water Stress Proteins", that are postulated to aid the plants survival.

For example, certain plants exposed to stress conditions produce a hormone called abcisic SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 3 acid (ABA) which helps plants close their stromata, thereby reducing the severity of the stress. Unfortunately, ABA is known to inhibit the formation of new leaves, to cause flowers and fruit to drop off, and to lead to a reduction in yield.

Most tropical plants are not believed to have evolved the ability to tolerate prolonged drought and/or freezing. Conversely, many temperate plants are known to have developed at least some ability to tolerate such conditions. The productivity of plant varieties in dry conditions, and after freeze, differ dramatically. For example, tobacco (Nicotiana spp.) produces fresh leaves that are highly sensitive to drought, and cannot be produced commercially in areas with a limited water supply and high degree of evaporation. In contrast to water stress, very little is known about proteins and genes which participate in freezing tolerance. However, it has been hypothesized that a major component of freeze tolerance may involve tolerance to dehydration (See, Yelenosky, Guy, L. (1989) Plant Physiol. 89: 444-451).

Another particular area of interest of late has been the development of plants with improved abilities to grow in salinized soil. Salinization of soil occurs when water supplies contain dissolved salt. Upon evaporation of water from such supplies, salts gradually accumulate in the soil. The progressive salinization of irrigated land compromises the future of agriculture in many of the most productive areas of our planet (Serrano, et al., Crit. Rev. Plant Sci., 13:121-138 (1994)). For example, arid regions offer optimal photoperiod and temperature conditions for the growth of most crops, but suboptimal rainfall. Artificial irrigation has solved the problem only in the short term as it has been found that soils in such environments frequently are rapidly salinized. To grow in salinized environments, plants must maintain a much lower ratio of Na/K in their cytoplasm than that present in the soil, preventing the growth of a number of plants, including food crops.

Physiological studies suggest that salt exclusion in the root, and/or salt sequestration in the leaf cell vacuoles, are critical determinants for salt tolerance (Kirsch, et al., Plant Mol. Biol., 32:543-547 (1996)). Toxic concentrations of sodium chloride (NaC1) build up first in the fully expanded leaves where NaCI is compartmentalized in the vacuoles. Only after their loading capacity is surpassed, do the cytosolic and apoplasmic concentrations reach toxic levels, ultimately leading to loss ofturgor, ergo plant death. It has been suggested that hyperacidification of the vacuolar lumen via the V-ATPase SUBSTITUTE SHEET (RULE 26) provides extra protons required for a Na+/H exchange-activity leading to the detoxification of the cytosol (Tsiantis, et al., Plant 9:729-736 (1996)). Salt stress is known to increase both ATP- and pyrophosphate (PPi)-dependent FH transport in tonoplast vesicles of, for example, sunflower seedling roots. Salt treatments also induce an amiloride-sensitive Na+/H exchange activity (Ballesteros, et al., Physiologia Plantarum, 99:328-334 (1997)). In the halophyte Mesembryanthemum crystallinum, high NaCl stimulates the activities of both the vacuolar H+-ATPase (V-ATPase) and a vacuolar Na+/H antiporter in leaf cells.

Yet another area of agricultural interest is to improve the yield of crop plants and to improve the aesthetic qualities of certain decorative plants. The yield of a plant crop, and the aesthetics of certain decorative plants, may be improved by growing plants that are larger than the wild-type plant in vegetative and/or reproductive structure. It is known in the art that certain growth factors may be used to increase plant and/or plant flower size. Unfortunately, application of such growth factors is costly and time consuming.

15 A need, therefore, exists for plants having improved stress resistance to drought and/or freeze, possessing larger size attributes than wild-type counterpart varieties, and having increased tolerance to salt in the soil in which they are growing.

SUMMARY OF THE INVENTION The present invention discloses a transgenic plant having upregulated expression of vacuolar pyrophosphatase. It has been found that plants displaying such upregulated S* activity are generally larger than wild-type counterparts, demonstrate improved stress resistance to drought and/or freeze, and have increased tolerance to salt in the media in which they are growing.

According to an embodiment of the invention, there is provided a drought and 25 freeze resistant transgenic plant comprising a polynucleotide sequence comprising a exogenous tonoplast pyrophosphate driven H+ pump gene operably linked to a promoter.

According to another embodiment of the invention, there is provided a drought and freeze resistant transgenic plant containing a polynucleotide sequence comprising a exogenous tonoplast pyrophosphate driven H+ pump gene operably linked to a double tandem enhancer of the 35S promoter.

According to another embodiment of the invention, there is provided a transgenic plant containing a polynucleotide sequence comprising a multiplicity of exogenous tonoplast pyrophosphate driven H+ pump genes operably linked to a double tandem enhancer of the 35S promoter, wherein the number of pyrophosphate driven H+ pump genes is sufficient to express a sufficient number of pyrophosphate driven H+ pumps on A595871spcci 4a the vacuolar membranes to produce drought and freeze resistance as compared to wildtype plants.

According to another embodiment of the invention, there is provided a transgenic plant which is tolerant to a salt, comprising one or more plant cells transformed with exogenous nucleic acid which increases expression of vacuolar pyrophosphatase (AVPI) in the plant.

According to another embodiment of the invention, there is provided a transgenic plant which grows in a concentration of a salt that inhibits growth of a corresponding nontransgenic plant.

According to another embodiment of the invention, there is provided a transgenic plant which is tolerant to a salt comprising an exogenous nucleic acid construct which is designed to overexpresses AVP1 or endogenous pyrophosphatase.

According to another embodiment of the invention, there is provided a transgenic plant obtained by introducing into a plant exogenous nucleic acid which increases is expression of vacuolar pyrophosphatase in the plant.

According to another embodiment of the invention, there is provided a transgenic plant which is tolerant to a salt, comprising one or more plant cells transformed with exogenous nucleic acid which increases expression of a vacuolar pyrophosphatase.

According to another embodiment of the invention, there are provided plant cells comprising exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant cell.

According to another embodiment of the invention, there is provided a method of making a transgenic plant which is tolerant to a salt comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar 25 pyrophosphatase in the plant to yield transformed cells in the plant, thereby producing a transgenic plant which is tolerant to the salt.

According to another embodiment of the invention, there is provided a method of making a transgenic plant which is tolerant to a salt comprising introducing into one or more cells of a plant a nucleic acid construct which is designed to overexpress AVPI to yield transformed cells thereby producing a transgenic plant which is tolerant to the salt.

According to another embodiment of the invention, there is provided a method of making a transgenic plant which is larger than its corresponding wild type plant comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, 35 thereby producing a transgenic plant which is larger than its corresponding wild type plant.

A595871spcci 4b According to another embodiment of the invention, there is provided a method of producing a transgenic plant which grows in salt water comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant which can grow in salt water.

According to another embodiment of the invention, there is provided a method of making a transgenic plant having increased flower size compared to its corresponding wild type plant comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant having increased flower size compared to its corresponding wild type plant.

Plants produced by the above methods of the invention are also provided.

Also provided are transgenic progeny of the plants of the invention, transgenic seeds produced by the transgenic plants of the invention, and progeny transgenic plants grown from the transgenic seeds.

According to another embodiment of the invention, there is provided a method of increasing the yield of a plant comprising introducing into one or more cells of a plant nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby increasing the yield of the plant. Transgenic plants with increased yield produced by this method are also provided, as are transgenic seeds therefrom, and transgenic progeny plants grown from said seeds.

According to another embodiment of the invention, there is provided a method of bioremediating soil comprising growing one or more transgenic plants and/or progeny thereof in the soil, wherein the transgenic plants and/or progeny thereof comprise 25 exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant.

According to another embodiment of the invention, there is provided a method of removing cations from a medium which can support plant growth comprising growing •one or more transgenic plants and/or progeny thereof in the medium, wherein the transgenic plants and/or progeny thereof comprise exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant.

Any suitable exogenous nucleic acid molecule which alters expression of vacuolar pyrophosphatase in the plant can be used to transform the transgenic plants in accord with the present invention. The exogenous nucleic acid can comprise nucleic acid that encodes 35 a vacuolar pyrophosphatase protein (an exogenous vacuolar pyrophosphatase), such as AVP 1, a functional portion thereof (peptide, polypeptide), or a homologue thereof, and/or nucleic acid that alters expression of the endogenous vacuolar pyrophosphatase of the plant into which the exogenous nucleic acid is introduced. By A595871speci WO 01/33945 PCT/US00/30955 "exogenous nucleic acid" it is meant a nucleic acid from a source other than the plant cell into which it is introduced, or into a plant or plant part from which the transgenic part was produced. The exogenous nucleic acid used for transformation can be RNA or DNA, cDNA, genomic DNA). In addition, the exogenous nucleic acid can be circular or linear, double-stranded or single-stranded molecules. Single-stranded nucleic acid can be the sense strand or the anti-sense strand. By a "functional portion" of a nucleic acid that encodes a vacuolar pyrophosphatase protein it is meant a portion of the nucleic acid that encodes a protein or polypeptide which retains a functional characteristic of a vacuolar pyrophosphatase protein. In a particular embodiment, the nucleic acid encodes AVP1, a functional portion or a homologue thereof.

Nucleic acid that alters expression of the endogenous vacuolar pyrophosphatase of the plant into which the exogenous nucleic acid is introduced includes regulatory sequences inducible, constitutive) which function in plants and antisense nucleic acid. Examples of regulatory sequences include promoters, enhancers and/or suppressors of vacuolar pyrophosphatase. The nucleic acid can also include, for example, polyadenylation site, reporter gene and/or intron sequences and the like whose presence may not be necessary for function or expression of the nucleic acid but can provide improved expression and/or function of the nucleic acid by affecting, for example, transcription and/or stability of mRNA). Such elements can be included in the nucleic acid molecule to obtain optimal performance of the nucleic acid.

The nucleic acid for use in the present invention can be obtained from a variety of sources using known methods. For example, the nucleic acid encoding a vacuolar pyrophosphatase AVP1) for use in the present invention can be derived from a natural source, such as tobacco, bacteria, tomato or corn. In one embodiment, the nucleic acid encodes a vacuolar pyrophosphatase that corresponds to a wild type of the transgenic plant. In another embodiment, the nucleic acid encodes a vacuolar pyrophosphatase that does not correspond to a wild type of the transgenic plant. Nucleic acid that alters expression of the endogenous vacuolar pyrophosphatase of the plant into which the exogenous nucleic acid is introduced regulatory sequence) can also be chemically synthesized, recombinantly produced and/or obtained from commercial sources.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 6 A variety of methods for introducing the nucleic acid of the present invention into plants are known to those of skill in the art. For example, Agrobacteriummediated plant transformation, particle bombardment, microparticle bombardment U.S. Patent No. 4,945,050; U.S. Patent No. 5,100,792) protoplast transformation, gene transfer into pollen, injection into reproductive organs and injection into immature embryos can be used. The exogenous nucleic acid can be introduced into any suitable cell(s) of the plant, such a root cell(s), stem cell(s) and/or leaf cell(s) of the plant.

Any suitable plant can be used to produce the transgenic plants of the present invention. For example, tomato, corn, tobacco, rice, sorghum, cucumber, lettuce, turf grass, ornamental larger flowers, larger leaves) and legume plants can be transformed as described herein to produce the transgenic plants of the present invention.

In addition, the transgenic plants of the present invention can be grown in any medium which supports plant growth such as soil or water (hydroponically).

A transgenic plant of the present invention is preferably tolerant to high salt concentrations in soil. By the term "salt" it is meant to include any salt, that is a compound formed when hydrogen of an acid is replaced by a metal or its equivalent, and includes, without limitation, salts comprising monovalent and divalent toxic cations, NaCI, KCI, CaC12, MgCl, CdCl, ZnCl, and sulfide salts.

Salt tolerance may be introduced into a plant of the present invention by transforming plant cells with exogenous nucleic acid which alters the expression of vacuolar pyrophosphatase in the plant such that expression is upregulated. Any suitable vacuolar pyrophosphatase, several of which have been cloned, can be used in the compositions and methods of the present invention Sarasian, et al., Proc. Natl.

Acad. Sci., USA, 89:1775-1779 (1992); Jenslerchl, et al., Molec. Biol., 29: 833-840 (1995); Kim, et al., Plant Physiol., 106:375-382 (1994)). In a particular embodiment, the present invention relates to a transgenic plant which is tolerant to salt comprising an exogenous nucleic acid construct which is designed to overexpress AVP1 (Sarasian, et al., Proc. Natl. Acad. Sci., USA, 89:1775-1779 (1992)). Transformation of the plant cells may be carried out in a whole plant, seeds, leaves, roots or any other plant part. Such transgenic plants are preferably altered such that they grow in a concentration of salt that inhibits growth of a corresponding non-transgenic plant. Transgenic progeny of the transgenic plants, seeds produced by the transgenic plant and progeny transgenic plants SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 7 grown from the transgenic seed, which are also the subject of the present invention, advantageously carry such salt tolerant trait. Plants may be regenerated from transformed cells to yield transgenic plants, which may be screened for certain levels of salt tolerance.

In a preferred embodiment, the exogenous nucleic acid encodes AVP1, or a homologue thereof. Preferably expression of the vacuolar pyrophosphatase in the plant is enhanced to an extent that the transgenic plant is tolerant to sodium chloride (NaCI) when the NaCI concentration is from about 0.2M to about 0.3M. A transgenic plant capable of growing in salt water may also be produced by introducing into one or more cells of a plant nucleic acid which upregulates expression of vacuolar pyrophosphatase in the plant to yield transformed cells. As used herein, "salt water" includes water characterized by the presence of salt, and preferably wherein the concentration of salt in the water is from about 0.2M to about 0.4M. In one embodiment, salt water refers to sea water.

The transgenic plants of the present invention can also be used to produce double transgenic plants which are tolerant to salt (about 0.2M to about 0.4M salt concentration). In one embodiment, the present invention relates to a double transgenic plant which is tolerant to salt comprising one or more plant cells transformed with exogenous nucleic acid which alters expression of a vacuolar pyrophosphatase and an Na /H antiporter in the plant. The vacuolar pyrophosphatase in an advantageous construct is AVP1, or a homologue thereof, and the NaI/Hantiporter is AtNHX1, or a homologue thereof. The present invention also encompasses transgenic progeny of the double transgenic plant, as well as seeds produced by the transgenic plant and a progeny transgenic plant grown from the seed.

Drought and/or freeze tolerance may also be introduced into plants by transforming plant cells with exogenous nucleic acid which alters the expression of vacuolar pyrophosphatase in the plant such that such expression is upregulated. In a preferred embodiment there is provided a substantially drought and/or freeze resistant transgenic plant which comprises a genome having one or more exogenously introduced vacuolar HI-translocating pump genes. A particularly preferred fertile transgenic plant eliciting drought and/or freeze tolerance, as well as the ability to grow in saline soils, comprises an isolated exogenous chimeric DNA construct encoding vacuolar H+translocating pump, preferably operably linked to a promoter, such as the 35-S promoter or any other strong promoter, including, without limitation, tissue specific promoters. The SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 8 transgenic plant may contain a polynucleotide sequence comprising an exogenous tonoplast pyrophosphate H pump gene operably linked to a promoter. In yet another particularly preferred drought and/or freeze resistant transgenic plant having the capacity to grow in saline soils, the polynucleotide sequence comprises an exogenous tonoplast pyrophosphate H1 pump gene operably linked to a double tandem enhancer of the promoter. A particularly preferred tonoplast pyrophosphate H+ pump gene is the AVPI gene.

Upregulation of expression of vacuolar pyrophosphatase by the methods described above may also be used to provide a plant having larger vegetative and/or sexual organs than wild type counterpart plants. That is, the present invention provides for a method of increasing the yield of a plant comprising introducing into one or more cells of a plant nucleic acid which alters expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby increasing the yield of the plant. The method can further comprise regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is larger than its corresponding wild type plant, thereby producing a transgenic plant which is larger than its corresponding wild type plant. Also encompassed by the present invention is a method of making a transgenic plant an ornamental plant) having increased flower size compared to its corresponding wild type plant comprising introducing into one or more cells of a plant nucleic acid which alters expression of vacuolar pyrophosphatase in the plant to yield transformed cells.

There is also disclosed in the present invention novel gene cassettes including cassettes comprising a tonoplast pyrophosphate driven H pump gene operably linked to a chimeric promoter, a novel gene cassette comprising a exogenous tonoplast pyrophosphate driven W pump gene operably linked to a promoter, as well as novel coding sequences comprising an exogenous tonoplast pyrophosphate driven H pump gene operably linked to a double tandem enhancer of the 35S promoter. Preferably such coding sequence is designed to overexpress AVP1.

There is also disclosed in the present invention novel expression vectors including an expression vector containing a polynucleotide sequence comprising a exogenous tonoplast pyrophosphate driven H pump gene operably linked to a double tandem enhancer of the 35S promoter and further operatively linked to a multiple cloning site, and an expression vector containing a polynucleotide sequence comprising a SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 9 exogenous tonoplast pyrophosphate driven If pump gene operably linked to a double tandem enhancer of the 35S promoter and further operatively linked to a heterologous coding sequence.

It is recognized by the present inventor, that the disclosed invention may have application to any plant, including, without limitation, crop plants, ornamental plants, grasses, shrubs, or any other plant found useful or pleasing to man.

BRIEF DESCRIPTION OF THE DRAWINGS The above description, as well as further objects, features and advantages of the present invention will be more fully understood with reference to the following detailed description when taken in conjunction with the accompanying drawings, wherein: Fig. IA is an overhead view of representative (out of 10 plants each) wild type (WT) and two independent transgenic lines and grown hydroponically for seven weeks on a 10 hour light/dark cycle; Figs. IB(1), 1B(2) and 1B(3) are a photomicrographs of the root and root hairs of representative five day old seedlings obtained from representative WT, 1' and 2' of Fig. IA grown parallel to the surface on vertical plant nutrient agar plates; Fig. IC is an immunoblot of membrane fractions isolated from wild type (WT) and two independent transgenic lines and overexpressing AVP-1; Fig. 2 is an overhead view of a representative wild type plant (WT) versus representative transgenic plants overexpressing AVP-1 and after exposure to 7 days of water deficit stress.

Fig. 3 is a perspective view of wild-type plants (WT) versus representative transgenic plants overexpressing AVP-I and grown in salty soil.

Fig. 4A is a schematic representation of a working model of the transporters involved in sodium sequestration at the yeast pre-vacuolar compartment; Nhxl antiporter), Vmal (vacuolar membrane H-ATPAse), Gefl (yeast CLC chloride channel), Enal (plasma membrane Na -ATPase).

Fig. 4B is a schematic representation of a working model of the transporters involved in sodium sequestration at the yeast pre-vacuolar compartment shown in Fig. 4A, which also includes Avpl thaliana vacuolar pyrophosphateenergized proton pump).

SUBSTITUTE SHEET (RULE 26) Fig. 5A and Fig. 5B are bar graphs showing the intracellular Na and K+ contents of wild-type yeast strains and of yeast strains carrying various mutations affecting sodium tolerance wherein the values are the mean of two determinations, and the bars represent the standard deviations.

Figs. 6A, 6B, 6C, when joined by matchlines A-A and B-B, is an alignment of the deduced amino acid sequences of NhX homologue from Arabidopsis AtNHX1 (SEQ ID NO: human HsNHE-6 (SEQ ID NO: 2) and yeast ScNHX1 (SEQ ID NO: identical residues are in black boxes, and dashes indicate gaps in the sequence, above alignment denote putative amiloride binding site from human NHE1 63 DVF- FLFLLPPI 73

(SEQ

ID NO: 4).

Figs. 7A and 7B are bar graphs of Na and K content of wild-type plants (WT) versus representative transgenic plants overexpressing AVP-1 (1 'and grown in salty soil.

Fig. 8 is a graph of the uptake of calcium into the 35SAVP-1 transgenic vacuolar membrane vesicles (squares) of 2' of Fig. 3 versus calcium uptake into vesicles obtained from wild type (WT) of Fig. 3.

Figs. 9A and 9B are illustrations demonstrating the theorized mechanism for a higher accumulation of solids into vacuoles via a proton driven function versus that of WT vacuoles.

20 DETAILED DESCRIPTION OF THE INVENTION Since plant vacuoles constitute 40 to 99% of the total intracellular volume of a mature plant cell, changes in the size of the vacuole have dramatic effects upon cell size G. Zhen, E. J. Kim, P. A. Rea, in The Plant Vacuole. (Academic Press Limited, 1997), vol. 25, pp. 298-337). The volume of the vacuole is controlled by ion and water fluxes S 25 mediated by pumps and transporters. In plants the driving force that triggers the movement of ions, solutes and water across membranes is a proton gradient. The activity of the vacuolar H+-pumps results in luminal acidification and the establishment of a H electrochemical potential gradient across the vacuolar membrane, which powers the secondary active transporters of inorganic ions, sugars, and organic acids. The activity of these transporters modulates cellular pH and ion homeostasis and leads to the accumulation of solutes required to generate the osmotic potential that promotes vacuolar expansion Sze, X. Li, M. G. Palmgren, The Plant Cell 11, 677-689 (1999)).

A595871spcci WO 01/33945 PCT/US00/30955 11 There are three distinct pumps that generate proton electrochemical gradients. One at the plasma membrane that extrudes H from the cell (PM H -ATPase) and two at the vacuolar membrane or other endomembrane compartments that acidify their lumen (the vacuolar type H-ATPase and H+-PPase) A. Leigh, in The Plant Vacuole L.

a. Sanders, Ed. (Academic Press, San Diego, California, 1997), vol. 25, pp. 171-194.).

Previous work has shown that a decrease in the levels of the A subunit of the vacuolar H'-ATPase of carrot, using an antisense construct, resulted in a plant with reduced cell expansion and altered leaf morphology P. Gogarten, et al., The Plant Cell 4, 851-864 (1992)). The present inventor has hypothesized that an increased supply of Iinto the vacuole could cause cell expansion. Recently, based on the theory that as the availability of protons in the vacuolar function of ion accumulation, it has been hypothesized by the same inventor that accumulation of solids in the vacuoles might be useful to protect against draught and to provide for a more freeze resistant plants.

The present inventor has recognized that plants have a number of vacuolar H+-translocating pumps, and that by upregulating their activity, increasing their expression, upregulating their transcription and/or translation, or increasing their copy number that one can increase accumulation of solids in the vacuole due to an increase in the availability of protons in the vacuoles. The inventor tested this hypothesis by increasing the copy number of the vacuolar H'-translocating pump, the inorganic pyrophosphatase or V-PPase that consists of a single polypeptide G. Zhen, E. J. Kim, P. A. Rea, in The Plant Vacuole (Academic Press Limited, 1997), vol. 25, pp. 298-337).

In Arabidopsis the V-PPase encoded by the A VP-I gene is capable of generating a H gradient across the vacuole membrane (tonoplast) similar in magnitude to that of the vacuolar H+-ATPase Sarafian, Y. Kim, R. J. Poole, P. A. Rea, Proc. Natl. Acad. Sci.

89, 1775-1779 (1992)). As would be understood by one of ordinary skill in the art, similar genes in other plants should function in a similar manner.

In one embodiment, a construct comprising a vacuolar pyrophosphatase gene operably linked to a promoter designed to overexpress the vacuolar pyrophosphatase an expression cassette) is used to produce the transgenic plants of the present invention. As used herein the term "overexpression" refers to greater expression/activity than occurs in the absence of the construct. In a particular embodiment, a construct comprising an AVP gene operably linked to a chimeric promoter designed to overexpress SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 12 AVP1 is used to produce the transgenic plants of the present invention. More particularly, the present invention relates to a construct wherein the AVPI gene is operably linked to a double tandem enhancer of a 35S promoter.

The transgenic plants of the present invention may find utility other than those associated with the food value or ornamental value. For example, the transgenic plants of the present invention may uptake different or more ions than their wild-type counterparts. As discussed below, studies with mutant yeast strains (enal) demonstrates that I--translocating pumps at the vacuole plays an important role in cation detoxification in higher plants (the plant components involved in an intracellular cation detoxification system being identified by complementing salt-sensitive mutants of the budding yeast Saccharomyces cerevisiae). Transgenic plants and/or progeny thereof comprising exogenous nucleic acid which alters expression of vacuolar pyrophosphatase in the plant in accord with such studies may be used to bioremediate soil and growth medium. Such plants can be used to remove cations monovalent and/or divalent cations) from a medium which can support plant growth soil, water). For example, transformed plants of the present invention can be used to remove sodium lead manganese (Mn) and/or calcium (Ca) ions from a medium which supports plant growth.

To demonstrate the effect that an increased supply of H into the vacuole would have on resistance to drought and/or freeze, and tolerance to salt growth, as well as size of the plants, the present inventor generated transgenic plants containing extra copies of a vacuolar proton pump, A VP-1.

Arabidopsis thaliana plants were transformed with constructs containing the A VP-1 gene. Transgenic lines containing extra copies of this gene were then isolated.

The A VP-1, open reading frame was cloned into the Xmal site of a modified pRT103 [R.

Topfer, V. Matzeit, B. Gronenbor, J. Schell and H-H. Steinbiss, Nucleic acid Research 5890 (1987)]. This vector contains a tandem repeat of the 35-S promoter. A HindIII fragment containing the 35-S tandem promoter, AVP-1 ORF and the polyadenylation signal was subcloned into the HindIII site of the pPZP212 vector P. Hajdukiewicz, Z.

Svab and P. Maliga, Plant Molecular Biology 25, 989-994 (1994)]. Agrobacteriummediated transformation was performed via vacuum infiltration of flowering Arabidopsis thaliana (ecotype columbia). Transgenic plants were selected by plating seeds of the transformed plants on plant nutrient agar plates supplemented with 25 mg/liter kanamycin.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 13 Plants were subsequently selected for two generations to identify transgenic plant homozygous for the transgene.

Fig. IA is an overhead picture of representative (out of 10 plants each) wild type (WT) and two independent transgenic lines and grown hydroponically for seven weeks on a 10 hour light/dark cycle. As can be seen in Fig. 1A, a visual comparison of transgenic line which expresses the AVP-1 protein at highest level, transgenic line and wild type demonstrates that the amount of AVP-1 correlates with the size of the plants. The mass of the transgenic plants was found to be greater than that of wild type. The dry weight of the entire transgenic plants, measured after 24 hours at 75 0

C

(n for transgenic lines 1' and 2' was found to be 1.5 and 3 times greater then that of wild-type (WT).

Fig. IB(I), Fig. IB(2) and Fig. IB(3) are photomicrographs (magnification: times 40; bar length on photograph 2mm) of the root and root hairs of representative five day old seedlings obtained from representative WT, 1'transgenic and 2' transgenic of Fig. IA grown parallel to the surface on vertical plant nutrient agar plates.

Seedlings of both transgenic lines 1' and 2' showed root hairs with an average length and 70% larger than wild-type (WT) root hairs (Fig. IB) (Root hair length along the whole root was determined from five members of each set of seedlings. An average of 80 root hairs per plant were measured). The length of the root hairs is correlated with the size of the vacuole, so the increased size of the root hair is likely to result from increased vacuolar volume. This compares with the Arabidopsis mutant rdh3 which has been reported to have reduced vacuolar volume and is a short plant with abnormally short root hairs E.

Galway, J. W. J. Heckman, J. W. Schiefelbein, Planta 201, 209-218 (1997)). It is recognized that the increased root structure will have a positive impact on soil erosion, nitrogen fixation in legumes, and will aid in water uptake by the plant.

Fig. IC is an immunoblot of membrane fractions isolated from wild type (WT) and two independent transgenic lines and overexpressing AVP-1. Total membrane fractions were isolated from shoots of eight week old wild type (WT) and AVP-1 transgenic plants and grown in a hydroponic media for 6 weeks. Shoots of plants homogenates were sequentially centrifuged for 15 and 30 min at 8 and 100 kg respectively. The 100kg membrane pellet was re-suspend in 10 mM Tris, pH 7.5, 150 mM NaCI, 1 mM EDTA, 10% glycerol and 1 mM PMSF Protein (10 mg) was separated SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 14 on a 10% SDS-PAGE, electroblotted and immunostained with antibodies raised against a KLH-conjugated synthetic peptide corresponding to the putative hydrophilic loop IV of the AVP-1 protein Sarafian, Y. Kim, R. J. Poole, P. A. Rea, Proc. Natl. Acad Sci. 89, 1775-1779 (1992)). PPase was detected by chemiluminescence. Fig. IC illustrates that the transgenic lines and express AVP-1 protein at higher levels than the wild type (WT) (that is, 1' 15% and 2' =50% more than WT).

As wheat that has been deprived of water is rendered more drought tolerant by an increase in cell K content (from 100 mM to 300 mM) Gupta, G. Berkowitz, P.

Pier, Plant Physiol 89, 1358-1365 (1989)), it is hypothesized (but the invention is not hereby limited by such theory) that the increased drought resistance of the AVP-1 transgenic plants may be a consequence of their higher vacuolar concentration of potassium that results in a increased water retention capability. Laboratory tests appear to confirm this.

Fig. 2 is an overhead view of a representative wild type plant (WT) versus representative transgenic plants overexpressing AVP-I and after exposure to 7 days of water deficit stress. Wild type and transgenic plants overexpressing A VP-I (Fig 3A) were tested for drought tolerance (24 0 After 7 days of water deficit stress wild type (WT) plants withered, whereas plants from both 35SA VP-i transgenic lines and 2') were turgid and alive. Furthermore, when the drought stressed plants were then watered, transgenic plants pursued normal growth, bolted and set seeds, whereas wild type plants died. The relative water content of leaves from wild type and 35SA VP-1 transgenic plants were determined along the water deficit stress, demonstrating increased water retention by the transgenic lines as compared to the WT plants.

While not illustrated in the accompanying illustrations, similar results may be seen with respect to freeze challenge 0°C) over a 24 hour or more period for a number of plant species. While not limited to such hypothesis, transgenic plants overexpressing AVP-1 and are believed to provide enhanced protection from freeze as compared to wild type (WT) plants due to the higher amounts of cations in the vacuoles. Higher amounts of cations confer a greater osmotic pressure that leads to a greater water retention capability endowing the plants not only with the ability to withstand low soil water potentials, but also providing greater protection from freezing that leads to significant desiccation of the plants.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 Fig. 3 is a perspective view of wild type plants (WT) versus representative transgenic plants overexpressing AVP-1 and grown in salty soil. Five wild-type plants (WT) and two AVP-1 overexpressing transgenic lines and were grown on soil in a 10 hour light/dark cycle. Plants were watered with a diluted nutrient solution (1/8 MS salts) for six weeks and subsequently watered with a diluted nutrient solution supplemented with NaCI. The concentration of NaCI began with 100 nM and was increased every four days by 100 mM. The photograph in Fig. 3 corresponds to plants at the tenth day in the presence of 300 mM NaCl. Fig. 3 illustrates that the two AVP-1 plant types and were significantly hardier in salty soil as compared to wild-type plants.

The fact that genetically engineered Arabidopsis thaliana plants that overexpress either A VPI (the pyrophosphate-energized vacuolar membrane proton pump, this work) or AtNHX1 (the Na'/H' antiporter, (Apse, et al., Science, 285:1256-1258 (1999)) and this work) are capable of growing in the presence of high NaCI concentrations strongly supports the strategy described herein. A double transgenic plant would be expected to demonstrate a further enhanced salt-tolerant phenotype. These Arabidopsis thaliana transporters or their counterparts may perform similar function in important agricultural crops. The increased size of 35S A VP1 Arabidopsis transgenic plants also contribute to potential yield increases in genetically engineered crops.

A Working Model of Cation Homeostasis in Plant Organelles While the present invention is not limited to any particular hypothesis, the present inventors have developed a working model for cation homeostasis in plant organelles which may explain the unexpected results discovered with respect to the transgenic plants disclosed herein.

In plants, most of the transport processes are energized by the primary translocation of protons. HF-translocating pumps located at the plasma membrane and tonoplast translocated H' from the cytosol to extracellular and vacuolar compartments, respectively (Rea, et al., Tonoplast Adenosine Triphosphate and inorganic Pyrophosphatase. In: Methods Plant Biochem., pp. 385-405, Academic Press Limited, London (1990)). The plant tonoplast contains two HI-translocating pumps; the V-ATPase and the inorganic pyrophosphatase or V-PPase. Their action results in luminal acidification and the establishment of a H' electrochemical potential gradient across the tonoplast (Davies, et al., The Bioenergetics of Vacuolar Hf Pumps. In: Plant SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 16 Vacuole, pp. 340-363, Leigh, Sanders, D. Academic Press, San Diego (1997)). The vacuolar membrane is implicated in a broad spectrum of physiological processes that include cytosolic pH stasis, compartmentation of regulatory Ca 2 sequestration of toxic ions such as Na', turgor regulation, and nutrient storage and retrieval. The vacuole constitute 40 to 99% of the total intracellular volume of a mature plant cell. The vacuolar proton pumping pyrophosphatase is a universal and abundant component of plant tonoplast capable of generating a steady-state trans-tonoplast Helectrochemical potential similar or greater than the one generated by the V-ATPase (Rea, et al., Tonoplast Adenosine Triphosphate and Inorganic Pyrophosphatase.

In:Methods Plant Biochem., pp. 385-405, Academic Press Limited, London (1990)).

Pyrophosphate (PPi) is a by-product in the activation or polymerization steps of a wide range of biosynthetic pathways and in plants serves as an alternative energy donor to ATP for sucrose mobilization via sucrose synthetase, for glycolysis via PPi: fructose-6phosphate phosphotransferase and for noplast energization via the vacuolar proton pumping pyrophosphatase (Stitt, Bot. Acta 111:167-175 (1998)).

Most of intracellular organelles, including clathrin-coated vesicles, endosomes, Golgi membranes and vacuoles have acidic interiors (Xie, X. et al., J. Biol.

Chem., 264:18870-18873 (1989)). This acidification is mediated by a proton-translocating electrogenic ATPase and in plant vacuoles also via a pyrophosphate-driven proton pump V-PPase (Davies, et al., The Bioenergetics of Vacuolar H' Pumps. In: Leigh R.A., Sanders, (eds) The Plant Vacuole, pp. 340-363, Academic Press, San Diego (1997); Zhen, et al., "The Molecular and Biochemical Basis of Pyrophosphate-Energized Proton Translocation at the Vacuolar Membrane Academic Press Limited (1997)). There exists a requirement of anion transport to maintain net electroneutrality (al-Awqati, A., Curr. Opin. Cell. Biol., 7:504-508 (1995)).

Fig. 4A is a schematic representation of a working model of the transporters involved in sodium sequestration at the yeast pre-vacuolar compartment; Nhxl (Na+/Hr antiporter), Vmal (vacuolar membrane H+-ATPase), Gefl (yeast CLC chloride channel), Enal (plasma membrane Na+-ATPase). The yeast member of the CLC voltage-gated chloride channel superfamily, Gefl, is required for copper loading in late- Golgi vesicles and for cation sequestration in the pre-vacuolar compartment in yeast (Gaxiola, et al., Proc. Natl. Acad Sci. USA, 95:4046-4050 (1998); Gaxiola, et SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 17 al., Proc. Natl. Acad. Sci. USA, 96:1480-1485 (1999); Example Furthermore, it has been shown that the defects of gef7 mutants can be suppressed by the introduction of the prototype member of the CLC superfamily, the Torpedo marmorata CLC-O or by the introduction of Arabidobsis thaliana CLC-c and CLC-d chloride channel genes (Hechenberger, et al., J. Biol. Chem., 271:33632-33638 (1996); Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 95:4046-4050 (1998)). Fig. 4B is a schematic representation of a working model of the transporters involved in sodium sequestration at the yeast prevacuolar compartment shown in Figure 4A, which also includes Avpl thaliana vacuolar pyrophosphate-energized proton pump).

While not wishing to be bound by theory, two observations led to the proposal of the model for Na sequestration in yeast illustrated in Figs. 4A and 4B. First, gef7 mutants are sensitive to high NaCl concentrations. Second, the Na+/H exchanger Nhxl is localized to the pre-vacuolar compartment (Nass, et al., J. Biol. Chem., 273:21054-21060 (1998)). The model proposed in Figs. 4A and 4B posits that Na sequestration by Nhxl depends on the vacuolar H*-ATPase and Gefl, the chloride channel. Gefl-mediated anion influx allows the establishment by the vacuolar HW-ATPase of a proton gradient sufficient in magnitude to drive the uphill accumulation ofNa* via Na/Hr exchange.

Based on such models, it was theorized that increasing the influx of protons into the postulated endosomal compartment should improve Na sequestration via the Nhxl exchanger. In order to increase the H availability the A. thaliana gain-of-function mutant gene A VP1-D that codes for the vacuolar pyrophosphate-energized proton pump was expressed (Figure 3B) (Zhen, et al., J. Biol. Chem., 272:22340-22348 (1997)).

This plant pump expressed in yeast restored the Na resistance of the test strain, but only if the strain had functional NHX1 and GEF1 genes. Furthermore, Geflp and Nhxlp colocalize within a common organelle, the pre-vacuolar compartment (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 96:1480-1485 (1999)). These results strongly support the model in Figs. 4A and 4B and indicate that the yeast pre-vacuolar compartment can be used to identify the elusive plant transporters involved intracellular sodium detoxification.

The model set forth in Figs. 4A and 4B is entirely consistent with the physiological data on the role of the vacuole in cation detoxification in higher plants.

Yeast and plant cells share pathways and signals for the trafficking of vesicles from the SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 18 Golgi network to the vacuole (Neuhaus, et al., Plant Mol. Biol., 38:127-144 (1998); (Paris, et al., Plant Physiol., 115:29-39 (1997); Sato, et al., J. Biol. Chem., 272:24530-24535 (1997); Vitale, et al., Trends Plant Sci., 4:148-154 (1999)).

Studies were therefore undertaken in yeast to identify the role of the vacuole in cation detoxification in higher plants.

Studies of Cation Sequestration Mechanism in Yeast Example 1: Functionality of AtNhxl and Avpl in Yeast Strains To test the sequestration models set forth in Figs. 4A and 4B, mutant yeast strains (enal) lacking the plasma membrane sodium efflux pump, which therefore must rely on the internal detoxification system in order to grow on high salt, were constructed.

The sequestration model (Nass, R. and Rao, J. Biol. Chem.. 273:21054-21060 (1998) and, Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 95:40464050 (1998)) of Figs. 4A and 4B predicts that the enal strain would become salt tolerant if one could enhance the availability of protons in the postulated endosomal compartment, that is with increased influx of protons, cytoplasmic Na would be sequestered via the Nhxl exchanger.

The yeast vacuolar ATPase is a multisubunit protein, so it is difficult to increase its activity by overexpressing any one of its subunits. Instead the same effect was achieved by increasing the influx of protons by expressing the A. thaliana A VPI gene in yeast. This gene encodes a single polypeptide that, when expressed in yeast, is capable of pumping protons into the lumen of the vacuole (Kim, et al., Proc. Natl. Acad. Sci.

USA, 91:6128-6132 (1994)). To ensure maximum activity of this proton pump, the E229D gain-of-function mutant of the A VP1 gene (A VPI-D) that has enhanced I pumping capability was expressed (Zhen, et al., J. Biol. Chem., 272:22340-22348 (1997)). Intracellular sodium and potassium content was determined for mutant and wildtype cells after growth on SD-ura medium with high NaCI content.

Materials and Methods Yeast strains and Plasmids Strains isogenic to W303 (ura3-1 canl-100 leu2-3, 112trpl-l his3-11, (Gaxiola, et al., EMBOJ., 11:3157-3164 (1992)) were employed. Plasmids pRG52 (-gefl::HIS3) (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 95:4046-4050 (1998)) and pRG197 (-nhxl::HIS3) were used to construct the deletions of GEF1 and NHXI SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/USOO/30955 19 genes, yielding strains RGY85 and RGY296, respectively. The enal.:HIS3 mutant was obtained from Fink Lab collection (L5709).

Method of Transformation Transformation of yeast cells was performed by using the lithium acetate method (Gietz, et al., Nucleic Acids Res., 20:1425 (1992)). Double mutants RGY324 (gefl::HIS3 enal::H1S3), RGY326 (nhxl::HIS3 enal:-:HIS3), and RGY343 (,gefl::HIS3 nhxi ::HIS3) were obtained by crossing the single-mutant strains. Double mutants were identified among the meiotic progeny by scoring for the phenotypes associated with each of the single mutants. Sporulation, tetrad dissection, and mating types were scored as described (Guthrie C. and Fink, Guide to Yeast Genetics and Molecular Biology (Academic, San Diego (1991)). Cells were grown in YPD yeast/2%peptone/2% dextrose; Difco), YPGAL yeast/2%peptone/2% galactose; Difco), SD (Difco; Synthetic medium with 2% Dextrose), or APG (APG is a synthetic minimal medium containing 10 mM arginine, 8 mM phosphoric acid, 2% glucose, 2 mTM MgSO 4 1 M KCI, 0.2 m.M CaCI 2 and trace minerals and vitamins) (Rodriguez-Navarro, A. and Ramos, J Bacteriol., 159:940-945 (1984)). MnC1 2 (Sigma), tetramethylammonium chloride (Sigma), NaCl (Sigma) or hygromycin-B (Sigma were added as indicated.

Wild type, L5709 (enal::HIS3), RGY324 (gefl::HIS3 enal::HIS3), and RGY326 (nhxl::HIS3 enal::HJS3) strains were transformed with pYES2 vector (Invitrogen) and plasmid pYES2-A VPI-E229D described in Zhen, et al., J. Biol.

Chem., 272:22340-22348 (1997). The strain RGY343 (gefl::HIS3 nhxl::HIS3), used for histochemnical analysis, was transformed with pRGI151 (GEFJ -GFP) (Gaxiola, et at.

Proc. Nati. Acad Sci. USA, 95:4046-4050 (1998)) and with pRIN73 [NHX-(-L) 3 1 (Nass, and Rao, J. Biol. Chem., 273:21054-21060 (1998)).

Wild-type and RGY296 (nhxl::HIS3) strains were transformed with vector pAD4 (Ballester, et at., Cell, 59:681-686 (1989)). RGY296 (nhxl::HIS3) was transformed with pRG3O08 (ADHJ::-AtNHXJ) (see Cloning ofA tNI).

Determination of Intracellular Sodium and Potassium Content Cells were grown overnight in SD-ura medium (Difco; synthetic medium with 2% dextrose without uracil). YPGAL yeast extract/2% peptone/2% galactose; Difco) media was inoculated with the overnight stocks and grow to an A 600 of 0.6. At this OD, NaCI was added to a final concentration of 0.7 M. The cells were incubated for 6 h, SUI3STrTUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 harvested by centrifugation, washed two times with 1.1 M sorbitol and 20 mM MgCI 2 and entracted with water for 30 min at 95 0

C.

The amount ofNa and K' in cells was determined at the University of Georgia Chemical Analysis Laboratory by an Inductively Coupled Plasma-MS (see world wide web at rserv/ugaedu/rsnew/chemicalanalysis/). Intracellular cation concentrations were estimated as described (Gaxiola, et al., EMBOJ., 11:3157-3164 (1992)) by using the intracellular water value calculated for cells grown in 1M NaCI.

Immunofluorescence The strain RGY343 (gefl::HIS3 nhxl::HIS3) was grown in SD-ura, -leu medium (Difco; synthetic medium with 2% dextrose without uracil and leucin) to midlogarithmic phase, 0.1 mg/ml hygromycin B was added, and the culture was incubated for 1 h at 30°C. Cells were fixed with 3.7% formaldehyde (Sigma) for 45 min at room temperature without agitation. Spheroplast formation, permeablization, washing, and antibody incubation was performed as described (Pringle, et al., in Immunofluorescence Methodsfor Yeast, eds. Guthrie, C. And Fink, G.F. (Academic, Sand Diego), Vol. 194 pp.565-602 (1991)). MAB HAl used as first antibody was from Babco (Richmond, CA). Cy3-conjugated goat anti-mouse IgG was from Jackson Immunoresearch. 4',6-Diamidino-2-phenylindole (Sigma) was added to mounting medium to stain mitochondrial and nuclear DNA.

Subcellular Fractionation and Western Analysis The strain RGY343 (ge7f::HIS3 nhxl::HIS3) was grown in APG medium (pH and lysates fractionated on a 10-step sucrose density gradient as described (Nass, R. and Rao, J. Biol. Chem. 273:21054-21060 (1998)). Aliquots of individual fractions (100 gg) were subjected to SDS/PAGE and transferred to nitrocellulose as described (Nass, R. and Rao, J. Biol. Chem., 273:21054-21060 (1998)). Western blots were probed with monoclonal anti-GFP (green fluorescent protein) antibody (1:10,000 dilution; CLONTECH), anti-hemagglutinin antibody (1:10,000 dilution: Boehringer Mannheim), and peroxidase-coupled goat anti-mouse antibody (1:5,000;) and developed by using the ECL enhanced chemiluminescence system (Amersham Pharmacia).

Cloning of AtNHX1 AtNHXI was cloned from a phage cDNA library of A. thaliana (Kieber, et al., Cell, 72:427-441 (1993)) (obtained from the Arabidopsis Biological Resource SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 21 Center) by probing with an expressed sequence tag (Arabidopsis Biological Resources Center, DNA Stock Center) containing a partial clone. A full-length clone (2.1 kB) was ligated into vector pSK2 (Stratagene) at the Notd sit, generating plasmid pRG293. The AtNHX1 ORF was amplified via PCR by using pRG293 as template and GGCCCGGGATGGATTCTCTAGTGTCGAAACTGCCTTCG (SEQ ID NO: 5) (italicized bases correspond to nucleotides 1-30 of the ORF) and T7 oligonucleotides. The PCR product was then digested with Xbal and Sail and ligated into pAD4 vector generating plasmid pRG308. The AtNHXI ORF was sequenced to verify the fidelity of the PCR product. The full-length sequence is longer than the ORF reported by the Arabidopsis Genome Initiative (A TM021B04.4), and has been deposited in GenBank (accession no.

AF106324).

Cloning of AVP1-D Vector pYES2 (Invitrogen) was introduced into wild-type, enal, enal nhxl, and enal gefl mutants. Plasmid pYes2-A VPI-D (Zhen, el al. J. Biol. Chem., 272:22340-22348 (1997)) was introduced into enal, enal nhxl, and enal ge7f mutants.

Five-fold serial dilutions (starting at 105 cells) of each strain were plated on YPGAL (1% yeast extract/2% peptone/2% galactose) with or without 0.5 M NaCl and incubated at 0 C for 2 days. Exponentially growing cells (wild-type and enal transformed with pYES2 vector and enal, enal nhxl, and enal gefl mutants carrying pYes2-A VP1-D) were exposed to 0.7M NaCI for 6 hours. Total cell extracts were prepared, and Na' and K concentrations were determined.

Results The enal mutant of the above construct lacks the plasma membrane sodium efflux pump and therefore must rely on the internal detoxification system to overcome sodium toxicity. Growth of the enal strain is sensitive to low concentrations of sodium (200 mM), concentrations that do not inhibit the growth of wild-type strains.

Overexpression of A VP1-D restored salt tolerance to salt-sensitive enal mutants. The restoration of salt tolerance to an enal strain by A VP1-D requires functional NHX1 and GEFI genes: enalnhxl A VPI-D and enal gef7 A VPI-D strains are salt sensitive.

Fig. 5A and Fig. 5B are bar graphs showing the intracellular Na and K+ contents of wild-type yeast strains and of yeast strains carrying various mutations affecting sodium tolerance wherein the values are the mean of two determinations, and the bars SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 22 represent the standard deviations. The intracellular Na* and K" contents of wild-type strains and of strains carrying various mutations affecting sodium tolerance were determined after 6 h of exposure to media supplemented with 0.7 M NaCl. The intracellular Na content in the enal mutant was seen to be 8-fold higher than in the wildtype strain. There was seen to be a consistent reduction in total cell Na in the enal AVP- D strain. The reason for this reduction is unknown. The enal A VP-D strain was found to be salt-resistant, even though its intracellular Na content was 4-fold higher than that of the wild type. In enal A VPI-D strains lacking either gef7 or nhxl enal gefl or enal nhxl), the Na content was not reduced to the extent that it was in the GEFI NHXI strain.

Taken together, the genetic and physiological data are consistent with the model that Nhxl, Gefl and Avpl cooperate to sequester sodium internally. As can be seen in the graphs, the Arabidopsis Vacuolar H+ -Pyrophosphatase (Avpl) was evidenced to confer salt tolerance to yeast enal mutants.

The intracellular K content was found to correlate with salt tolerance and is inversely correlated with the Na content of the strains (Fig. 4B). The wild-type K concentration was at 100 mM, but was reduced to 20 mM in the enal mutant.

Interestingly, in an enal strain that overexpresses the A VPI-D gene, the intracellular concentration of K was restored almost to wild-type levels (Fig. 4B). However, A VPJ-D overexpression failed to restore wild-type levels of intracellular potassium unless both NHxl and GEF1 were functional (See, the double mutants enal nhxl or enal gefl in Fig.

4B).

As shown herein, intracellular Na detoxification in yeast requires functional Na+/H- exchanger (Nhxl) and chloride channel (Gefl), and they co-localize to a pre-vacuolar compartment (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 96:1480- 1485 (1999)). When the Arabidopsis thaliana homologue of the yeast NHX1 gene (AtNHX1) was cloned and its function in the nhx I yeast mutant tested, the AtNHX1 gene was found to be able to suppress partially the cation sensitivity phenotypes of nhxl mutants. Fig. 6 is alignment of the deduced amino acid sequences ofNhXl homologue from Arabidopsis AtNHX1 (SEQ ID NO:1), human HsNHE-6 (SEQ ID NO: 2) and yeast ScNHX (SEQ ID NO:3); identical residues are in black boxes, and dashes indicate gaps in the sequence, above alignment denote putative amiloride binding site from human NHEI 6

DVF-FLFLLPPI"

7 3 (SEQ ID NO: 4).

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 23 Example 2: Functionality of. and Co-localization of, Geflp and Nhxlp in Yeast Strains The NHXJ and GEFI genes, which have been identified as important in sodium detoxification, are also required for the detoxification of other cations. An investigation was made with respect to the viability of yeast strains mutant with respect to gefl and nhxl (enal) in the presence of toxic cations, in light of the model set forth in Figs. 4A and 4B.

The sequestration model postulates not only a functional connection between the anion channel Gefl and sodium exchanger Nhxl but also predicts that these two proteins co-localize within a common compartment. Because previous studies indicated that Nhxl localizes to a pre-vacuolar compartment (Nass, R. and Rao, J.

Biol. Chem., 273:21054-21060 (1998)), experiments were also performed to determine whether Gefl and Nhx 1 proteins co-localize to this compartment.

Materials and Methods The strain RGY419 (gefl nhxl) was transformed with plasmids pRG 151; GEFI-GFP and pRIN73; NHXI-(HA) 3 Transformants were grown in SD (Difco; synthetic medium with 2% dextrose). To determine the sensitivity of such transformants to toxic cations, five-fold serial dilutions (starting at 10 s cells) of the indicated strains were grown at 30 C for 2 days on YPD yeast extract/2% peptone/2% dextrose) with the addition of either 3 mM MnCI 2 0.45 M tetramethylammonium (TMA), or 0.05 mg/ml hygromycin B (HYG) as indicated.

Two studies were undertaken to demonstrate co-localization of Geflp and Nhxlp.

Distribution of fluorescence and immunodetection of subcellular fractions in gefl nhxl cells transformed with two constructs: a GEFI-GFP fusion and a NHX1-

(HA)

3 -tagged fusion were determined. When the cells reached OD 60 0 0.5, hygromycin B (Sigma) was added to a final concentration of 0.1 mg/ml and the cells were incubated for min at 30 C. Cells were fixed and stained with antibodies to HA epitope and 4',6diamidino-2-phenylindole (DAPI). Cells were viewed by charge-coupled device microscopy and optically sectioned by using a deconvolution algorithm (Scanalytics, Billerica, MA) (Kennedy, et al., Cell, 89:381-391 (1997)); (Bar 1 The migration properties of the Geflp and Nhxlp in sucrose gradients was also determined to provide evidence of co-localization of Nhxl (HA) 3 and GEF -GFP.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 24 The strain RGY419 (gefl nhxl) was transformed with plasmids pRGI51; GEF1-GFP and pRIN73; NHX1-(HA) 3 and grown in APG medium (Rodriguez-Navarro, A. and Rea, P.A., J. Biol. Chem., 159:940-945 (1984)). Such was converted to spherop!asts, lysed, and fractionated on a 10-step sucrose gradient (18-54%) as described (Sorin, et al., J. Biol.

Chem., 272:9895-9901 (1997) and Antebi, A. and Fink, Mol. Biol. Cell, 3:633-654 (1992)). Western blots showed the distribution of Gefl-GFP and Nhxl-HA.

Results Gefl mutants were found to be sensitive to 3 mM MnCl 2 0.45 M tetramethylammonium chloride and to 0.05 g/ml hygromycin-B. The nhxl mutant was also found to be sensitive to tetramethylammonium chloride and hygromycin. The extreme sensitivity of the nhxl mutant to hygromycin may provide an important tool for assaying nhxl function.

It was found that hemagglutinin (HA)-tagged Nhxl and Gefl-GFP fusion protein co-localize as shown via epifluorescence deconvolution microscope. Persistence of signal coincidence on 900 rotation of the image further supports co-localization of the two transporter proteins in these cells. The co-localization of Nhxl (HA) 3 and GEFI-GFP is also supported by the co-migration of the two proteins in sucrose density gradients of membrane preparations obtained from cells expressing the tagged proteins. The sedimentation behavior of the membrane fraction containing both proteins is consistent with that ofa pre-vacuolar compartment (Nass, R. and Rao, J. Biol. Chem., 273:21054- 21060 (1998)). Gefl-GFP (but not Nhxl) is also present in Golgi fractions, consistent with previous studies (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 95:4046-4050 (1998), Schwappach, et al., J. Biol. Chem., 273:15110-15118 (1998)).

Example 3: Capacity ofA. thaliana Homolog ofNHX1 to Suppress Hygromycin Sensitivity of Mutant Yeast The yeast strain described herein provides an important tool for identifying genes that mediate salt tolerance in other organisms. To test the utility of this system, a sequence from Arabidopsis (See Materials and Methods) with very high homology to the S. cerevisiae NHXY ORF was identified and used an expressed sequence tag (see Materials and Methods) to obtain a full-length clone of this Arabidopsis gene. An alignment of the amino acid sequences of Nhxl homologues from Arabidopsis (AtNhxl), SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 human (HsNhe6), and yeast (ScNhxl) reveals segments of amino acid identity and similarity within predicted transmembrane domains (Fig. 6A-C). However, it is important to note that despite these relationships, neither the C-terminal regions of AtNhxl and ScNhxl show a high degree of homology (Fig. 6A-C).

A characteristic of mammalian Na+/H antiporters is their inhibition by amiloride. A putative amiloride binding site 63

DVFFLFLLPPI

1 73 (SEQ ID NO: 4) has been defined via point mutants in the human NHE1 antiporter gene (Counillon, et al., Proc. Natl. Acad Sci. USA, 90:45084512 (1993)). AtNhxl, HsNhe-6 and ScNhxl have an almost identical sequence (Fig. However, attempts to inhibit the activity of either Nhxl or AtNhxl in yeast cultures with amiloride were unsuccessful.

The extreme sensitivity of yeast nhxl mutants to hygromycin permitted the testing of whether the cloned Arabidopsis AtNHX1 ORF could provide Na/H exchange function in yeast. Vector pAD4 (Ballester, et al., Cell, 59:681-686 (1989) was introduced into wild-type and nhxl strains. Plasmid pRG308; ADH; AtNHXI was introduced into nhxl mutants as indicated. Five-fold serial dilutions (starting at 10 s cells) of the indicated strains were grown at 30 C for 2 days on YPD or on YPD supplemented with 0.05 mg/ml hygromycin Serial dilutions of the same strains were grown on APG medium (see Materials and Methods) or on APG supplemented with 0.4 M NaCI (Rodriguez-Navarro, A. and Ramos, J. Bacteriol., 159:940-945 (1984).

The At NHY1 gene is capable of suppressing the hygromycin sensitivity of the nhxl mutant. The AtNHX1 gene also suppressed the NaCI sensitivity of nhxl mutant but only under conditions in which the K availability was reduced. However, AtNHXI was not capable of rescuing the Na sensitive growth phenotype of the double mutant enal nhxl overexpressing the A VPJ-D gene.

Example 4: Generation of Gain-of-Function Yeast AtNHX Mutants Materials and Methods Gain of function mutants of the AtNHX that enhance salt tolerance were generated in the enal yeast by mutagenizing the cloned gene to make a mutant library.

This library was used to transform the salt sensitive yeast mutant enal and clones with an enhanced salt tolerant phenotype.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 26 Other genes that show similarity to the AtNHX1 gene, as reported by the Arabidopsis Genome Initiative (AGI), were also expressed in the mutant yeast to form gain-of-function mutants. It is believed that some of these AtNHXI homologues are plasma membrane transporters, so their function in yeast are frequently pH dependent, requiring precise composition and pH of the medium used for screening for success.

Identification of plasma membrane transporters helps to engineer plants with an enhanced salt tolerance due to a reduced sodium uptake. In addition, plant cDNA expression libraries in yeast are used to identify other families of transporters involved in NaCI detoxification.

To generate gain of function mutants of the AtNHX a method for introducing random mutations developed by Stratgene (Epicurian Coli XL 1-Red competent Cells Cat#200129) was used. The method involves the propagation of a cloned gene into a strain deficient in the three primary DNA repair pathways. The random mutation rate in this strain is about 5000-fold higher than that of wild-type. A library of the mutated AtNHX gene was transformed into the enal yeast mutant and screened for salt tolerance. Yeast transformation was performed as described by Schiestl and coworkers (Gietz, el al., Nucl. Acid Res. 20:1425 (1992), incorporated by reference in its entirety herein). An alternative to the XL -Red random mutagenesis strategy is a PCR approach described by Fink and coworkers (Madhani, et al., Cell, 91:673-684 (1997)).

To test AtNHX I homologues the same strains and conditions used for AtNHXI (Gaxiola, et Proc. Natl. Acad. Sci. USA, 96:1480-1485 (1999)) were used initially. However, if these screening strains and/or conditions did not work, new ones are worked out. When dealing with plasma-membrane AtNHXl homologues pH conditions of the assay media were found to be crucial.

Results The overexpression of the A. Thaliana gain-of-function mutant gene A VPI- D increases the intracellular detoxification capability in yeast (Gaxiola, et al., Proc.

Nail. Acad. Sci. USA, 96:1480-1485 (1999)). It is hypothesized (although the inventors are not limited by such hypothesis) that the latter is due to an increased influx of H' into the vacuolar compartment thereby improving Na sequestration via the Nhxl exchanger.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 27 Conclusions from Yeast Cation Sequestration Studies The yeast studies described above provide evidence for the importance of the pre-vacuolar pH for intracellular Na sequestration in yeast. Overexpression of the plant H -pyrophosphatase (Avpl) confers salt tolerance to yeast only in those strains containing a functional chloride channel (Gefl) and the Na+/HI exchanger (Nhx l).

These data support a model in which the Nhxl Na+/Hi exchanger acts in concert with the vacuolar ATPase and the GEF1 anion channel to sequester cations in a pre-vacuolar compartment. Several studies suggest that the pre-vacuolar compartment may be derived both from the plasma membrane and the late Golgi. These vesicles are likely involved in the assembly of the vacuole or delivery of cargo to this organelle. It is reasonable to expect that these pre-vacuolar vesicles detoxify cations by sequestration, thereby lowering their concentrations in the cytoplasm and in other organelles.

The yeast system described herein permits the functional assessment of diverse heterologous proteins in salt tolerance: chloride channels, H pumps, and Na'/IH exchangers and other cation/He exchangers or cation/bicarbonate symporters. The system is robust and flexible. The function of the Arabidopsis chloride channels (Gaxiola, R.A., et al., Proc. Natl. Acad Sci. USA, 95:4046-4050 (1998), Hechenberger, et al., J. Biol.

Chem., 271:33632-33638 (1996)), HI pump, and Na /H exchanger can be assayed in the corresponding yeast mutant. Despite the inability of At NHXI to suppress all the phenotypes of the yeast nhxl mutant, the fact that it suppresses some phenotypes, coupled with the DNA homology between AtNHXI and yeast NHXI, indicates that the plant gene carries out a similar function to that of the yeast homologue. The observation that the AtNHX1 gene suppresses the sensitivity of the nhxl mutant to hygromycin but provides only a weak Na detoxification phenotype could be a consequence either of differential regulation of the transporters in the two organisms or of distinct cation transport selectivities.

The regulation of AtNHXI by salt and the ability of the plant gene to suppress the yeast nhxl mutant suggest that the mechanism by which cations are detoxified in yeast and plants may be similar. Indeed, previous work suggested that vacuolar sodium accumulation in salt-tolerant plants may be mediated by a tonoplast Na /IH antiporter that utilizes the proton-motive force generated by the vacuolar H+- ATPase (V-ATPase) and/or H -translocating pyrophosphatase (V-Ppase; refs. Barkla, SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 28 et al., Symp. Soc. Exp. Biol., 48:141-153 (1994), Zhcn, et al., The Molecular and Biochemical Basis of Pyrophosphate-Energized Proton Translocation at the Vacuolar Membrane (Academic, San Diego), Kirsh, M, et al., Plant Mol. Biol., 32:543-547 (1996)).

The finding described herein that both gefl and nhxl mutants are hypersensitive to hygromycin indicate that the level of resistance to hygromycin depends on the function of the vacuolar and pre-vacuolar organelles. Yeast mutants impaired in K uptake (trkl) are hypersensitive to hygromycin (Madrid, et al., J. Biol. Chem., 273:14838-14844 (1998)); reduced K uptake hyperpolarizes the plasma membrane potential and drives the uptake of alkali cations such as hygromycin. Mutations that reduce the H' pumping activity of the plasma membrane H -ATPase, Pmal, depolarize the plasma membrane potential and confer resistance to hygromycin (McCusker, et al., Mol. Cell. Biol., 7:4082-4088 (1987)). Thus, mutants such as gefl or nhxl that affect the pH or membrane potential of the vacuolar and pre-vacuolar compartments may be expected to affect hygromycin compartmentation.

Transgenic Plants With Upregulated Vacuolar Hi-translocating Pump Activity Further support for the role of the Arabidopsis AtNHX1 gene in salt homeostasis is provided by the observation that its expression is induced in salt-stressed plants (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 96:1480-1485 (1999)).

Arabidopsis thaliana, in particular, has been used as a host model plant to demonstrate that overexpression of these genes results in salt tolerance in the plant. A recent report shows that the overexpression ofAtNHX1 gene in transgenic Arabidopsis thaliana promotes sustained growth in soil watered with 200 mM NaCI plus 1/8 M.S. salts under short-day cycle conditions (Apse, et al., Science, 285:1256-1258 (1999)). It is worth noting that every addition of 1/8 M.S. salts provides 2.5 mM potassium reducing the stringency of the NaCI stress, and that a short-day cycle reduces oxidative stress.

Example 5: Enhanced Expression of At NHX1 Gene in Salt-Stressed Plants Materials and Methods A. thaliana plants (ecotype Columbia) were grown aseptically on unsupplemented plant nutrient agar without sucrose (Haughn, G.W. and Somerville, C., Mol. Gen. Genet., 204:430-434 (1986)) for 15 days at 19 0 C and under continuous SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 29 illumination. NaCI or KCI was added to a final concentration of 250 mM, and the plants were incubated for 6 h. Total RNA from tissue of salt-treated and untreated plants was isolated (Niyogi, K.K. and Fink, Plant Cell, 4:721-733 (1992)), Hybond-N (Amersham) membranes were hybridized with a 3 2 P-Labeled DNA probe from plasmid pRG308. Hybridization was performed at 65 0 C overnight. Washes were performed at with 0.2% standard saline citrate (SSC)/0.1% SDS (Ausebel, et al., Curr.

Protocols in Mol. Biol. (Wiley, NY) (1988)). 18S probe was used as loading control (Unfried, et al., Nucleic Acids Res., 17:7513 (1989)). MACBAS 2.4 program was used to quantify the relative amount of RNA.

Results The NaCl stress increased AtNHXI mRNA levels 4.2-fold, whereas KCI promoted only a 2.8-fold increase. This increase in mRNA level produced by sodium resembles that described for the yeast NHX1 gene (Nass, R. and Rao, J. Biol. Chem., 273:21054-21060 (1998)). RNA tissue blot hybridized with AtNHX1. Ten micrograms of total RNA from 15-day old plants exposed to 250 mM NaCl or KC1 for 6 h and a control grown without salt was subjected to electrophoresis on a denaturing formaldehyde gel.

The blot was hybridized with a probe internal to AtNHXl ORF. An 18S ribosomal probe was used as a loading control.

Example 6: Salt tolerance of Transgenic plants overexpressing AtNHXI Materials and Methods Transgenic plants that overexpress the AtNHX1 were generated using Agrobacterium-mediated plant transformation. The transgenic AtNHX1 was expressed using a double tandem enhancer of the 35S promoter of CaMV (Topfer, et al., Nucl.

AcidRes., 15:5890 (1987)).

wild-type plants and 15 35SAtNHXI transgenic were grown on a 12 hours-day cycle for 20 days. During this period plants were watered every 5 days with a diluted nutrient solution (1/8 M.S. salts). 200 mM NaCI was added to the watering solution at day 21 and at day 33 plants were watered with a nutrient solution containing 300 mM NaC1. Plants were photographed 10 days after the last NaCI treatment.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 Results Transgenic plants were found to be significantly less affected than wild type controls when watered with 300 mM NaC1.

Example 7: Salt tolerance of Transgenic plants overexpressing 35SA VPI Materials and Methods A transgenic Arabidopsis thaliana plant was engineered to overexpress the A VPI wild-type gene using the double tandem enhancer of the 35S promoter (Topfer, R., et al., Nucl. Acid Res., 15:5890 (1987)). A VP1 encodes the pyrophosphate-energized vacuolar membrane proton pump from Arabidopsis (Zhen, et al., J. Biol. Chem., 272:22340-22348 (1997)). Previous investigations suggest that the A VP1 gene is present in a single copy in the genome of Arabidopsis (Kim, et al., Plant Physiol., 106:375- 382 (1994)), however, a sequence homologous, but not identical, to A VP1 on chromosome one has been tentatively designated as ORF F9K20.2 on BAC F9K20 by the Arabidopsis Genome Initiative (AGI).

Transgenic plants that overexpress AVP were generated using Agrobacterium-mediated plant transformation. The transgenic A VP1 was expressed using a double tandem enhancer of the 35S promoter of CaMV (Topfer, et al., Nucl. Acid Res., 15:5890 (1987)). 15 wild-type plants and 15 35SA VP1 transgenics were grown on a 24 hours-day cycle for 16 days. During this period plants were watered every 4 days with a diluted nutrient solution (1/8 M.S. salts). 200 mM NaCI was added to the watering solution at day 17 and at day 27 plants were watered with nutrient solution containing 250 mM NaCl. Plants were photographed 10 days after the last NaCl treatment. Identical conditions and treatment as described in Example 6 were used.

Results Five different lines of 35SA VP1 plants showed an enhanced salt tolerance as compared to wild-type plants in the T2 stage. However, the most dramatic phenotype was apparent in the homozygous T3 plants. These transgenic plants are larger than wildtype plants. Furthermore, homozygous 35SA VP1 plants showed sustained growth in the presence of 250 mM NaCI plus 1/8 M.S. salts when grown in a 24 hours light regimen.

When 35SA VP1 plants were grown under short-day cycle conditions (12 hour day/light SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 31 cycle) sustained growth in the presence of 300 mM NaCI plus 1/8 M.S. salts was observed.

Example 8: Growth of Wild Type Plants and 35SAVPI Transgenic Plants in Hydroponic Solution The reduced availability of fresh water for standard agriculture may force the use of alternative agricultural arts. It is conceivable that with salt tolerant crops the use of hydroponics with seawater will create a new era in crop production. Hydroponic culture has been reported to increase plant growth and provide stress-free root and shoot material (Gibeaut, et al., Plant Physiol., 317-319 (1997)). Another important advantage of hydroponic culture is that it allows one to alter the ionic composition in a more accurate manner than in soil. These advantages could be important for the physiological studies of salt stress.

Conditions for hydroponics culture ofArabidopsis plants were established and their performance in increasing concentrations of NaCl in their media were tested.

Materials and Methods In one test, hydroponically grown wild type and 35SA VPI transgenic plants were generated. Wild type and 35SA VP1 transgenic plants were grown in solution culture on a 12 hour light cycle for 65 days.

In another test, wild type and 35SA VPI transgenic plants were grown in solution culture on a 12 hours light cycle for 20 days. Starting at day 21, NaCl concentration was increased in a stepwise fashion by 50 mM increments every 4 days.

Plants were photographed after 4 days in the presence of 200 mM NaCI.

And yet in another hydroponic test, transgenic plants were challenged with a commercial seawater formula that contains the complete ionic composition present in the oceans. 35SAVP1, 35SAtNHX1 single and double transgenics were grown together with wildtype Arabidopsis thaliana plants under hydroponic conditions for four weeks in a short day illumination cycle (Gibeaut, et al., Plant Physiol., 317-319 (1997)). Then every four days an equivalent to 50mM NaCI of Tropic Marin sea salt (worldwide web at thatpetplace.com) is added. This artificial sea water mix includes all of the other major and trace elements present in real sea water. Growth was monitored and physiological parameters, such as sodium content and distribution was determined.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 32 Results When wild type and 35SA VPI transgenic plants were grown hydroponically the size differences in root, leaves and stems among wild type and VPI transgenic plants were found to be dramatic, with 35SA VPI transgenic plant parts being much larger.

When NaCI concentration were increased stepwise by 50 mM every 4 days (Apse, et al., Science, 285:1256-1258 (1999), 35SA VPI transgenic plants appeared healthy in the presence of 200 mM NaCI while wild type controls showed severe deleterious effects in their leaves and stems.

35SAtNHX1 single and double transgenics that were grown together with wildtype Arabidopsis thaliana plants under hydroponic conditions for four weeks in a short day illumination cycle (Gibeaut, et al., Plant Physiol., 317-319 (1997)) and then challenged every four days with an equivalent to 50mM NaCl of Tropic Marin sea salt were found to grow in the sea salt solution. Wildtype Arabidopsis thaliana plants did not.

Example 9: Effect of Overexpression of Arabidopsis thaliana Proton Transporters in Tomato Plants The effects of the overexpression of these Arabidopsis thaliana proton transporters (AVP1 and AtNHXl) in a more agriculturally important plant, the tomato plant, was examined. It is believed that increasing the salt-tolerance of tomato plants will likely have important economic repercussions.

The tomato homologues of AVPI and AtNHXI were isolated and the corresponding chimeras to overexpress them were constructed (Bidone, et al., Eur. J.

Biochem., 253: 20-26 (1998); Burbidge, et al., J. Exper. Botany, 48:2111-2112 (1997)). The genes were introduced via Agrobacterium-mediated infection of calli.

Tissue culture methods were used to regenerate transformed plants. The plants were assayed for salt tolerance as well as physiological parameters, such as sodium content and distribution.

Tomato transformation with 35S AVP1 and with 35S AtNHXI constructs was performed as described by McCormick (McCormick, Transformation of tomato with Agrobacterium tumefaciens. In: Plant Tissue Culture Manual, pp. 1-9, Lindsey, K.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 33 Kluwer Academic Publishers, Dordrecht, The Netherlands (1991)). TO and TI transgenics were analyzed by polymerase chain reaction and DNA gel blotting for the presence and copy number of AVP1 and AtNHXI transgenes. Heterozygous and homozygous plants were identified after segregation analysis of each transcend within TI seeds. Homozygous plants were assayed for salt tolerance and as well as physiological parameters, such as sodium content and distribution. Degenerated oligos based on conserved sequences present in AVP1 and AtNHXI homologues were designed. These degenerated primers were used in RT-PCR reactions with cDNAs made from poly(A)+RNA from tomato. The resulting PCR fragments were used as probes to isolate the full length cDNA clones from commercial libraries Stratagene Cat#936004). A similar strategy was described by Caboche and coworkers (Quesada, et al.. Plant Mol.

Biol., 34:265-274 (1997)).

Results Positive test results indicate that the sequestration model described herein is also applicable to an important crop.

Fig. 7 is a graph ofNa and K content of wild-type plants (WT) versus representative transgenic plants overexpressing AVP-1 and grown in salty soil.

Five wild-type plants (WT) and two AVP-1 overexpressing transgenic lines and 2') were grown on soil in a 10 hour light/dark cycle. Plants were watered with a diluted nutrient solution (1/8 MS salts) for six weeks and subsequently watered with a diluted nutrient solution supplemented with NaCl. The concentration of NaCI began with 100 nM and was increased every four days by 100 mM. The photograph corresponds to plants at the tenth day in the presence of 300 mM NaCl. Parts of the plant above ground were harvested after 24 hours in the presence of 200 mM NaCI and their fresh weigh measured.

After 48 hours at 75 0 C, the dry weight was measured. Na and K+ content was determined by atomic absorption. Values in the graphs of Fig. 4 are the mean SE (n As can be seen from the graphs Na and K+ content in the transgenic lines and was significantly higher than that of wild-type counterparts.

Fig. 8 is a graph of the uptake of calcium into the 35SAVP-1 transgenic vacuolar membrane vesicles (squares) of 2' of Fig. 4 versus calcium uptake into vesicles obtained from wild type (WT) of Fig. 4. Wild-type plants (open circles) and transgenic plants from line 2' of Fig. 4 were grown hydroponically for nine weeks on a 10 hour light SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 34 cycle. Vacuolar membrane vesicles were added to buffer containing 250 mM sorbitol, mM BTP-Hepes pH 8.0, 50 mM KCI, 1.5 nM MgSO 4 and 10 pM Ca". This mix was incubated at 20 0 C for 10 minutes before adding 200 pM PPi to trigger the reaction. Ca" ionophore A23187 was added to a final concentration of 5 gg/ml to dissipate the Ca"' gradient. Aliquot (200 pl) were filtered at the indicated times and washed with cold buffer as described As is evidenced by the graphs, the transgenic plants from line 2' have greater calcium uptake than wild-type plants.

The above data is consistent with the hypothesis that transgenic plants overexpressing A VP-1 have an enhanced I-I pumping capability at their tonoplast and that an enhanced f supply results in greater ion accumulation in the vacuole through the action of H-driven ion transporters. To further support this theory, Ca" uptake capability of wild type and transgenic vacuolar membrane vesicles was determined.

It is well documented that Ca+ enters the plant vacuole via a Ca"/HW antiporter S. Schumaker, H. Sze, Plant Physiol. 79, 1111-1117 (1985)). Furthermore, the genes encoding the Arabidopsis thaliana Ca+/HI antiporters CAX1 and CAX2 have been isolated and characterized D. Hirschi, Zhen, K. W. Cunningham, P. A.

Rea, G. R. Fink, Proc. Natl. Acad. Sci. USA 93, 8782-8786 (1996)). Fig. 8 shows that Ca" uptake in the 35SA VP-1 transgenic vacuolar membrane vesicles is 36% higher than it is in vesicles obtained from wild type. Application of the Ca" ionophore A23 lowered the counts to background levels demonstrating the tightness of the vesicles (Fig 8) (K.

S. Schumaker, H. Sze, Plant Physiol. 79, 1111-1117 (1985)).

While not limited by such theory, a model consistent with the enhanced drought and freeze tolerance of the transgenic plants overexpressing the A VP-1 gene is depicted in Figs. 9A and 9B. The model depicts how an increase in the number of AVP-1 pumps in the vacuole of transgenic plants can provide more HI that will permit the secondary transporters to import greater amounts of cations into the lumen of the vacuoles. Higher amounts of cations confer a greater osmotic pressure that leads to a greater water retention capability endowing plants to withstand low soil water potentials.

Example 10: Double Transgenic Plant with 35SA VPI and Overexpression of the pyrophosphate-energized vacuolar membrane proton pump AVP1 likely increases the availability of FI in the lumen of the vacuole, and the SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 AtNHX Na+'/H antiporter uses these H to sequester Na cations into the vacuole.

Therefore, higher expression of these transporters likely maximizes the sequestration capability of the vacuole.

To generate transgenic Arabidopsis plants that overexpress both genes AVPI and AtNHXI, T3 35SAVPI plants are used as females and T3 35SAtNHX1 plants are used as males. Female plants are hand-emasculated and anthers from freshly opened flowers of donor plants are harvested. With these anthers the emasculated plants are pollinated by touching the anthers onto the stigmas. The pollinated flowers are labeled and any remaining opened or unopened flowers from the same female plant are removed to avoid any confusion at harvest. The harvested seeds are sterilized using a 50% sodium hypochloride solution and mixed vigorously for 5 minutes and rinsed with water thoroughly. The sterilized seeds are stored in soft agar over night at 4 0 C. Then they are sprinkled onto solidified kanamycin-hygromycin selective medium. The 35S A VP construct has the neomycin phosphotransferase 11 gene that confers kanamycin tolerance in plants while the 35S AtNHXI construct has a modified hygromycin B phosphotransferase that confers hygromycin tolerance in plants. The resistant seedlings are transplanted into soil and to the hydroponic media to be tested for their salt-tolerant phenotype.

A transgenic Arabidopsis thaliana plant to overexpress the A. thaliana gain-of-function mutant gene A VPJ-D (Zhen, et al., J. Biol. Chem., 272:22340-22348 (1997)) is engineered using the same double tandem enhancer of the 35A promoter described above (Topfer, et Nucl. Acid Res., 15:5890 (1997)). Plants overexpressing the gain of function mutant gene will likely show an enhanced phenotype.

These plants are characterized in parallel with the 35SAVP1, 35SAtNHXsingles and doubles trangenics. The A. thaliana gain-of-function mutant gene A VP1-D is subcloned into plasmid pRT103 carrying the 35S promoter and the polyadenylation signal of CaMV (Topfer, et al., Nucl. Acid Res., 15:5890 (1997)). A HindIII fragment containing the chimeric 35SA VP-D gene is subcloned into pBIBhyg (Becker, Nucl. Acid Res., 18:203 (1990)). The resulting T-DNA vector is transformed into Agrobacterium tumefaciens strain GV3101 via electroporation, and used for subsequent vacuum infiltration of Arabidopsis thaliana ecotype Columbia (Bechtold, et al., C.R. Jeances Acad. Sci. Ser.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 36 IIISci. Vie, 316:1194-1199 (1993)). Integration is confirmed on Southern blots ofT3 plants and expression monitored on Northern blots of positive T3 plants.

Example 11: Comparative Transport Study With Vacuoles From The Roots Of Wild- Type and 35S A VPI Transgenic Plants A study was undertaken to determine if the vacuoles of 35S A VP1 transgenic plants show a higher proton transport activity dependent on pyrophosphate.

These determinations were done with root and shoot tissues separately from plants grown hydroponically. The transgene could show a tissue-specific regulation despite the promoter.

In order to compare the PPI-dependent H' translocation activities of wildtype and 35SA VP1 transgenic plants sealed tonoplast-enriched vesicles from roots and leaves of the above plants are prepared. The homogenization and differential centrifugation procedure described by Rea and Turner (Rea, et al., Tonoplast Adenosine Triphosphate and Inorganic Pyrophosphatase. In: Meth. Plant Biochem., pp.

385-405, Academic Press limited, London (1990)) is followed. II translocation is assayed fluorimetrically using acridine orange (2.5 M) as transmembrane pH difference indicator in assay media containing vacuole membrane-enriched vesicles as described by Rea and coworkers (Zhen, et al., J. Biol. Chem., 272:22340-22348 (1997)). The assay media contains 300 M Tris-PPi, 50mK KC1, 2.5 pM acridine orange, 5mM Tris- Mes (pH Intravesicular acidification is triggered with the addition of 1.3 mM MgSO4 and terminated with the addition of the protonophore FCCP at 2.5 gM.

Fluorescence is measured at excitation emission wavelengths of 495 and 540 nM, respectively, at a slit width of 5 nM (Zhen, et al., J. Biol. Chem., 269:23342-23350 (1994)). A further test to support that the H translocation is A VPI driven is the addition of the specific inhibitor aminomethylenediphosphonate (Zhen, et al., Plant Physiol., 104:153-159 (1994)).

Example 12: Determination Of The Na'/K Ratios In Leaves And Stems Of The Transgenic Plants Toxic concentrations ofNaCl build up first in the fully expanded leaves where NaC I is compartmentalized in the vacuoles. Exposure to NaC1 can disrupt or SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 37 reduce K' uptake leading to K+ deficiency and growth inhibition (Wu, et al., Plant Cell, 8:617-627 (1996). A cytosolic consequence of reduced K content and high Na is the inhibition of important enzymes. An example of such enzymes is the bisphosphate nucleotidase of yeast whose activity is more sensitive to Na when K content is low (Murguia, JR., et al., Science, 267:232-234 (1995).

Measurements may be taken to demonstrate that the transgenic plants described herein have an increased vacuolar capacity to sequester Na in their leaves cells or elsewhere. To determine the Na /K ratios in leaves and stem S wild-type and A VP /35S AtNHXI double and single transgenics in hydroponic conditions (Gibeaut, et al., Plant Physiol., 317-319 (1997) are grown. NaCI is added to the growth media in a stepwise fashion starting with 50 mM up to 250mM (Apse, et al., Science, 285:1256-1258 (199). At every point the rosette and the stems of the treated plants are collected and their weight is determined. The samples are dried out in an oven at and their dry weight is determined. The dry samples are boiled in a determined volume of water and their Na and K+ contents determined via atomic absorption spectrophotometry (Apse, et al., Science, 285:1256-1258 (1999); Gaxiola, R, et al., EmboJ., 11:3157- 2164 (1992)).

Example 13: Determination Of Whether 35S A VP1 Transgenic Plants Are Larger Because Their Cells Are Larger Or Because They Have More Cells, Or Both The shoot meristems labeling index is compared with one of the wild-type plants. Morphological and anatomical observations measuring and counting cells of leaves, roots and stems are performed. To determine if 35S A VPI transgenic plants are larger because they have more cells, their shoot meristems labeling index is compared with the one of wild-type plants.

To measure the DNA synthesis or cell proliferation 5-Bromo-2'-deoxyuridine (BrdU) that can be incorporated into DNA in place of thymidine may be used.

Cells that have incorporated BrdU into DNA are detected using a monoclonal antibody against BrdU monoclonal antibody and an anti-mouse Ig-alkaline phosphatase as a second antibody. The bound anti-BrdU monoclonal antibody is visualized by light microscopy and the ratio between DAPI stained and BrdU positives established. The protocol is a SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/USOO/30955 38 modification of the one published by Chiatante and coworkers (Levi, et al., Physiol.

Plant. 71:68-72 (1987)) and the BrdU labeling and detection kit II from Boehringer Mannheim. The plants are exposed for different times to the BrdU labeling medium and then fixation, paraffin embedding and sectioning is performed as described by Meyerowitz and coworkers (Drews, et al., Plant Mol. Biol. Rep., 5:242-250 (1988)).

For observation of leaf tissue, fresh tissues are embedded in 5% agarose and slice them with a microslicer. For primary root observation, seedlings are fixed for 4hr in 50% ethanol, 5% acetic acid, and 3.7% formaldehyde at room temperature, dehydrate them in graded ethanol series, permeate them with xylene, and infiltrate them with paraffin. Eight-micrometer sections are stained with 0.05% toluidine blue and cells are counted under a microscope. As an alternative for the visualization and determination of cell size the method described by Greenberg and coworkers (Rate, et al., The Plant Cell, 11:1695-1708 (1999)) is followed.

Example 14: Isolation Of Mutants In The Transporters Genetic approaches are very powerful in analyzing complex biological traits (Serrano, Crit. Rev. Plant Sci., 13:121-138 (1994)) Reverse genetics is a very important new tool for plant biologists. The generation of a good collection of tagged knockouts by Sussman and coworkers (Krysan, et al., Proc. Natl. Acad. Sci. USA.

93:8145-8150 (1996)) has open a very important avenue for the analysis of gene disruptions in Arabidopsis.

The Arabidopsis Knock-out Facility of the University of Wisconsin Madison (world wide web at biotech.wisc.edu/NewServicesAndResearch /Arabidopsis) is used to search among the 60,480 Arabidopsis (ecotype WS) lines that have been transformed with the T-DNA vector pD991 for the presence of T-DNA inserts within AtCLC-c, AtCLC-d, AVPI, AtNHX1 and their homologues. The phenotypes of the above knock-outs will shed light towards the understanding of the physiological roles of these transporters in normal and stress conditions. An initial characterization of the knockout plants includes testing for their salt tolerance and their Na+/K' ratios. The generation of double knock-outs via crosses help to further understand the interaction among the transporters as well as the crosses with the 35SA VP1 and the 35SAtNHX1 transgenic plants.

SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCTIUS00/30955 39 To search for Arabidopsis knock-out PCR primers are designed following the guidelines detailed in the University of Wisconsin web site. Tested primers are sent to UW-Madison, where 62 PCR reactions that are sent to us for Southern blot analysis are performed. Positive PCR products are sequenced. If the sequence reveals that there is a T-DNA inserted within the gene the gene specific primers are sent for another set of PCR reactions in order to determine which of the 9 possible pools of 225 contains the knockout.

After identifying the pool of interest, 25 tubes of seeds are screened for the individual plant carrying the T-DNA knock-out.

Example 15: Cation Detoxification In Plant Cells The studies described herein together with other evidence strongly indicate that yeast and plants share pathways and signals for the trafficking of vesicles from Golgi network to the vacuole (Gaxiola, et al., Proc. Natl. Acad. Sci. USA, 96:1480-1485 (1999); Marty, "The Biogenesis of Vacuoles: Insights from Microscopy. In: The Plant Vacuole, 1-42, Leigh, R.A. and Sanders, Academic Press, San Diego (1997); Bassham, et al., Plant Physiol, 117:407-415 (1998)).

Without wishing to be bound by theory, it is believe likely by the present inventor that in both systems a pre-vacuolar compartment is a dynamic entity that detoxifies the cytoplasm from toxic cations and delivers its cargo either to the vacuole, or directly to the cell exterior. Both the gefl chloride channel and Nhxl Na+/H exchanger have been localized to the yeast pre-vacuolar compartment (Gaxiola, et al., Proc.

Natl. Acad Sci. USA, 96:1480-1485 (1999)). The behavior of the gefl-GFP chimera in yeast cells in vivo have been monitored indicating that its localization varies depending the environmental conditions. Furthermore, it has been shown that two of the four A.

thaliana CLC chloride channel genes CLC-c and -dare capable of suppressing gefl mutant phenotypes implying a similar localization (Gaxiola, et al., Proc. Natl. Acad.

Sci. USA, 95:4046-4050 (1998)).

In order to understand how and where this cation detoxification takes place in plant cells the intracellular localization of GFP chimeras of AVPI, AtNHX1 and AtCLC-c and -d (Hong, et al., Plant Physiol., 119:1165-1175 (1999)) is monitored in vivo. Confocal microscopy is also used to address co-localization of the different transporters. For this purpose HA-tagged versions or antibodies of the transporters under SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 study are required (Guiltinan, et al., Meth. Cell Biol., 49:143-151 (1995); Jauh, G. et al., Plant Cell, 11:1867-1882 (1999); Mullen, et Plant. 12:313-322 (1997)).

For the constructions of the GFP-chimeras the soluble versions GFP with improved fluorescence in A. thaliana reported by Davis and Viestra (Davies, Viestra, "Soluble derivatives of green fluorescent protein (GFP) for use in Arabidopsis thaliana, http:/ brindabella.mrc-lmb.cam.ac.uk/IndexGFP.html (1998)) are used. Two types of GFP-chimeras are made, namely a set under the regulation of the native promoter and another set under the regulation of the 35S promoter. The resulting T-DNA vectors containing the GFP-chimeras are transformed into Agrobacterium tumefaciens strain GV3101 via electroporation, and used for subsequent vacuum infiltration of Arabidopsis thaliana ecotype Columbia (Bechtold, et al., C.R. Jeances Acad Sci. Ser. III Sci. Vie, 316:1194-1199 (1993)). For the hemagglutinin (HA) epitope tagging a PCR strategy designed for yeast but modified to tag plant genes expressed in yeast vectors is used.

Futcher and coworkers designed vectors containing the URA3 yeast gene flanked by direct repeats of epitope tags (HA) (Schneider, etal., Yeast, 11:1265-1274 (1995)).

Via PCR the tag-URA3-tag cassette is amplified such that the resulting PCR fragment possess homology at each end to the gene of interest. In vivo recombination in yeast is then used to direct the integration of the PCR-chimera to the plasmid carrying the plant ORF of interest, transformants are selected by the URA phenotype. The URA3 gene is "popped out" when positive transformants are grown in the presence of acid. The vector carrying the plant gene has a selection marker different than the URA3 gene.

In conclusion, the manipulation of vacuolar V-PPases in economically important crops could provide an important avenue for crop improvement. Drought and freeze tolerant cultivars could provide new agricultural approaches in areas lost due to drought or minimal rainfall, as well as to provide farmers with protection from unanticipated frosts (freezing rain etc.). Such crops may also be able to be raised on soils considered too saline for wild type crops.

While the invention has been described with respect to preferred embodiments, those skilled in the art will readily appreciate that various changes and/or modifications can be made to the invention without departing from the spirit or scope of SUBSTITUTE SHEET (RULE 26) WO 01/33945 PCT/US00/30955 41 the invention as defined by the appended claims. All references cited in this specification are herein incorporated by reference to the same extent as if each individual reference was specifically and individually indicated to be incorporated by reference.

SUBSTITUTE SHEET (RULE 26) 41a SEQUENCE LISTING <110> University of Connecticut Whitehead Institute Gaxiola, Roberto A.

<120> STRESS-RESISTANT OVERSIZED TRANSGENIC PLANTS CAPABLE OF GROWING IN SALINIZED SOIL <130> 883933.0048PCT <140> PCT/US00/30955 <141> 2000-11-10 <150> 09/644,039 <151> 2000-08-22 <150> 60/226,223 <151> 2000-08-18 <150> 60/164,808 <151> 1999-11-10 <160> <170> PatentIn version 3.1 <210> 1 <211> 571 <212> PRT <213> Arabidopsis thaliana <400> 1 Asn Leu Asp Ser Leu Val Ser Lys Leu Pro Ser Leu Ser Thr Ser Asp 1 5 10 His Ala Ser Val Val Ala Leu Asn Leu Pro Val Ala Leu Leu Cys Ala 20 25 Cys Ile Val Leu Gly His Leu Leu Ser Ser Asn Arg Trp Met Asn Lys 35 40 Ser Ile Thr Ala Leu Leu Ile Gly Leu Gly Thr Gly Val Thr Ile Leu 50 55 Leu Ile Ser Lys Gly Lys Ser Ser His Leu Leu Val Phe Ser Glu Asp 65 70 75 Leu Phe Pro Ile Tyr Leu Leu Pro Pro Ile Ile Pro Asn Ala Cys Phe 90 Gin Val Lys Lys Lys Gin Phe Phe His Asn Phe Val Thr Ile Asn Leu 100 105 110 Pro Cys Ala Val Gly Thr Ile Ile Ser Cys Thr Ile Ile Ser Leu Cys 115 120 125 Val Thr Gin Phe Pro Lys Lys Leu Asp Ile Gly Thr Phe Asp Leu Cys 130 135 140 Asp Tyr Leu Ala Ile Cys Ala Ile Phe Ala Ala Thr Asp Ser Val Cys 145 150 155 160 A595871spcci 41 b Thr Leu Gin Val Leu Asn Gin Asp Giu Thr Val1 As n Phe Leu 225 Tyr Met Ile His Thr 305 Asp Thr Arg Lys Trp 385 Lys Ile Met Thr Pro 465 Phe Aia His 210 Giy Phe Aia Leu Asn 290 Leu Aia Ser Aia Asn 370 Ser Phe Thr Leu Thr 450 Leu Cys Ile 195 Leu Aia Cys Tyr Thr 275 Vali Se r Leu Ile Aia 355 Gin Giy Thr Ser Thr 435 Ser Leu Giu Gin Leu Aia Arg Leu 260 Val1 Thr Phe Asp Aila 340 Phe Ser Leu Arg Thr 420 Lys Met Asp Cys Ser Cys Thr His 245 Ser Pro Giu Leu Ile 325 Val1 Vali Arg Met Aia 405 Ile Pro Leu Gin Val1 Phe Asn Cys 230 Ser Tyr Phe Ser Aia 310 Asp Ser Phe Lys Arg 390 Giy Thr Leu Ser Asp 470 Vali Asp Phe 215 Leu Thr Met Cys Ser 295 Arg Lys Ser Pro Ile 375 Cys His Val1 Ile Asp 455 Ser Asn Leu 200 Leu Ile Asp Leu Giy 280 Arg Thr Trp Ile Leu 360 Asn Ala Thr Cys Ser 440 Asp Phe Asp 185 Thr Tyr Ser Arg Ala 265 Ile Ile Phe Arg Leu 345 Ser Phe Val1 Asp Leu 425 Tyr Asn Ile 170 Ala His Leu Aia Giu 250 Arg Val Thr Ile Ser 330 Met Phe Asn Ser Val1 410 Phe Leu Thr Giu Pro Thr Leu Phe Tyr 235 Vali Leu Met Thr Phe 315 Val1 Gly Leu Met Met 395 Arg Ser Leu Pro Pro 475 Leu Ser As n Leu 220 Val1 Ala Phe Ser Lys 300 Leu Ser Leu Ser Gin 380 Aia Gly Thr Pro Lys 460 Se r Leu Val1 His 205 Leu Ile Leu Asp His 285 His Tyr Asp Vali Asn 365 Val1 Leu Asn Val His 445 Ser Cys Tyr Val1 190 Arg Ser Lys Met Leu 270 Tyr Thr Vali Thr Met 350 Leu Vali Ala Ala Vai 430 Gin Ile Asn Ser 175 Val1 Ala Thr Lys Met 255 Ser Thr Phe Cys Pro 335 Val Ala Ile Tyr Ile 415 Phe Asn His His Leu Phe Ala Leu Leu 240 Leu Cys Trp Ala Met 320 Gly Gly Lys Trp Asn 400 Met Gly Ala Ile Asn 480 Val Pro Arg Pro Asp Ser Ile Arg Gly Phe Leu Thr Arg ProThAr 485 49049 Thr Arg 495 41c Thr Val His Tyr Tyr Trp Arg Gin Phe Asp Asp Ser Phe Met Arg Pro 500 505 510 Val Phe Cys Cys Arg Gly Phe Val Pro Phe Val Pro Gly Ser Pro Thr 515 520 525 Glu Arg Asn Pro Pro Asp Leu Ser Lys Ala Glu Leu Ala Phe Gly Asp 530 535 540 His Glu Leu Val Ile Arg Gly Thr Arg Leu Val Leu Pro Met Asp Asp 545 550 555 560 Ser Glu Pro Pro Leu Asn Leu Leu Asp Asn Thr 565 570 <210> 2 <211> 664 <212> PRT <213> Homo sapiens <400> 2 Met Ala Arg Arg Cys Trp Arg Arg Ala Pro Leu Arg Arg Cys Val Cys 1 5 10 Ser Ser Pro Arg Ala Arg Lys Leu Met Arg Pro Leu Trp Leu Leu Leu S* 20 25 Ala Val Gin Val Phe Asp Trp Ala Gly Ala Ser Asp Gly Gly Gly Cys 35 40 Lys Ala Arg Ala Met Asp Lys Lys Ile Val Ser Glu Lys Gin Ala Glu 55 Glu Ser His Arg Gin Asp Ser Ala Asn Leu Leu Ile Pro Ile Leu Leu 65 70 75 Leu Thr Leu Thr Ile Leu Thr Ile Trp Leu Phe Lys His Arg Arg Ala 85 90 Arg Phe Leu His Lys Thr Cys Leu Ala Met Ile Tyr Gly Leu Leu Val 100 105 110 Gly Leu Val Leu Arg Tyr Gly Ile His Val Pro Ser Asp Val Asn Asn 115 120 125 Val Thr Leu Ser Cys Glu Val Gin Ser Ser Pro Thr Thr Leu Leu Val 130 135 140 Thr Phe Asp Pro Arg Val Phe Pro Asn Ile Leu Leu Pro Pro Ile Ile 145 150 155 160 Pro Ile Ala Cys Tyr Ser Leu Lys Arg Arg His Phe Phe His Asn Leu 165 170 175 Cys Ser Ile Leu Ala Tyr Ala Phe Leu Gly Thr Ala Ile Ser Cys Phe 180 185 190 Val Ile Cys Ser Ile Met Tyr Gly Cys Val Thr Leu Met Lys Val Thr 195 200 205 41d Cys Gin Leu Ala Gly Asp Phe Tyr Phe Thr Asp Cys Leu Leu Phe His 210 215 220 Ala Ile Val Ser Ala Thr Asp Pro Val Thr Val Leu Ala Ile Phe Asn 225 230 235 240 Glu Leu Gln Val Asp Pro Glu Leu Tyr Ala Leu Leu Phe Cys Glu Ser 245 250 255 Val Leu Asn Asp Ala Val Ala Ile Val Leu Ser Ser Ser Ile Val Ala 260 265 270 Tyr Gin Pro Ala Cys Asp Asn Ser His Thr Phe Asp Val Thr Ala Met 275 280 285 Phe Lys Ser Ile Cys Ile Phe Leu Gly Ile Phe Ser Gly Ser Phe Ala 290 295 300 Met Gly Ala Ala Thr Cys Val Val Thr Ala Leu Val Thr Lys Pro Thr 305 310 315 320 Lys Leu Arg Glu Phe Gin Leu Leu Arg Thr Gly Leu Phe Phe Leu Met 325 330 335 Ser Trp Ser Thr Phe Leu Leu Ala Arg Ala Trp Cys Phe Thr Cys Val 340 345 350 Val Ala Val Leu Phe Cys Gly Ile Thr Gin Ala His Tyr Thr Tyr Asn S, 355 360 365 Asn Leu Ser Thr Glu Ser Gin His Arg Thr Lys Gin Leu Phe His Leu S**370 375 380 Leu Asn Phe Leu Ala Arg Asn Phe Ile Phe Ser Tyr Met Cys Leu Thr *385 390 395 400 Leu Phe Thr Phe Gin Asn His Val Phe Asn Pro Thr Phe Val Val Gly 405 410 415 o Ala Phe Val Ala Ile Phe Leu Gly Arg Ala Ala Asn Ile Tyr Pro Leu 420 425 430 w Ser Leu Leu Leu Asn Leu Gly Arg Arg Ser Lys Ile Cys Ser Asn Phe 435 440 445 Gin His Met Met Met Phe Ala Gly Leu Arg Cys Ala Asn Ala Phe Ala 450 455 460 Leu Ala Ile Arg Asp Thr Ala Thr Tyr Ala Arg Gin Met Met Phe Ser 465 470 475 480 Thr Thr Leu Leu Ile Val Phe Phe Thr Val Trp Val Phe Cys Gly Gly 485 490 495 Thr Thr Ala Met Leu Ser Cys Leu His Ile Arg Val Gin Val Asp Ser 500 505 510 Asp Gin Glu His Leu Gly Val Pro Glu Asn Glu Arg Arg Thr Thr Lys 515 520 525 Ala Glu Ser Ala Trp Leu Phe Arg Met Trp Tyr Asn Phe Asp His Asn 530 535 540 41e Tyr Leu Lys Pro Leu Leu Thr His Ser Cys Pro Pro Leu Thr Thr Thr 545 550 555 560 Leu Pro Ala Cys Cys Gly Pro Ile Ala Arg Cys Leu Thr Ser Pro Gin 565 570 575 Ala Tyr Glu Asn Gin Glu Gin Leu Lys Asp Asp Asp Ser Asp Leu Ile 580 585 590 Leu Asn Asp Gly Asp Ile Ser Leu Thr Tyr Gly Asp Glu Thr Val Asn 595 600 605 Thr Lys Pro Ala Thr Ser Ser Ala Pro Arg Arg Phe Met Gly Asn Ser 610 615 620 Ser Glu Asp Ala Leu Asp Arg Lys Pro Val Phe Leu Asp Asn Val Ser 625 630 635 640 Pro Ser Leu Gin Asp Ser Ala Thr Gin Ser Pro Ala Asp Phe Ser Ser 645 650 655 Gin Asn His Arg His Cys Pro Ala 660 <210> 3 <211> 527 <212> PRT S <213> Saccharomyces cerevisiae <400> 3 Met Leu Ser Lys Val Leu Leu Asn Ile Ala Phe Lys Val Leu Leu Thr 1 5 10 Thr Ala Lys Lys Ala Val Asp Pro Asp Asp Asp Asp Glu Leu Leu Pro 25

S

Ser Pro Asp Leu Pro Gly Ser Asp Asp Pro Ile Ala Cys Asp Pro Asp 40 Val Asp Leu Asn Pro Val Thr Glu Glu Met Phe Ser Ser Trp Ala Leu 50 55 Phe Ile Met Leu Leu Leu Leu Ile Ser Ala Leu Trp Ser Ser Tyr Tyr .o 65 70 75 5

S

Leu Thr Gin Lys Arg Ile Arg Ala Val His Lys Thr Val Leu Ser Ile 90 Phe Tyr Gly Met Val Ile Gly Leu Ile Ile Arg Met Ser Pro Gin His 100 105 110 Tyr Ile Gin Asp Thr Val Thr Phe Asn Ser Ser Tyr Phe Pro Asn Val 115 120 125 Leu Leu Pro Pro Ile Ile Leu Asn Ser Cys Tyr Glu Leu Asn Gin Val 130 135 140 Asn Phe Phe Asn Asn Met Leu Ser Ile Leu Ile Pro Ala Ile Pro Gly 145 150 155 160 41 f Thr Phe Tyr Ser Ala Vai Val le Cys Ile Ile Leu Tyr Ile Trp, Thr Pro Val1 Phe Glu 225 Gin Ala Leu Arg Ala 305 Gin Cys Tyr Ala Thr 385 Thr Glu Ile Ser Ser 465 Leu Cys Asn 210 Ser Lys Cys Ile Tyr 290 Ile Phe Ile Gin Leu 370 Val1 Ala Giu Asn Asp 450 Asn Cys Ala 195 Ala Leu Phe Leu Cys 275 Pro Ser Val1 Thr Met 355 Ala Leu Cys Asp Leu 435 Asn Lys Leu 180 Thr Tyr Leu His Phe 260 Ile Gin Ile Asn Cys 340 Met Leu Val1 Met Thr 420 Leu As n Asn 165 Glu Leu Lys As n Cys 245 Leu Leu Ile Cys Trp 325 Giu Thr Giy Val1 Leu 405 Ser Asn Ser Leu Ser Ser Val1 Asp 230 Gin Met Val1 Arg Val1 310 Ile Asn Phe Ile Val1 390 Giu Asp Cys Pro Pro 470 Gly Ala Asp 215 Ala Pro Thr Al a Ser 295 Ala Tyr Ile Trp Gin 375 Val1 Val1 Asp Ser Asp 455 Asn Asp Thr 200 Pro Ile Ala Phe Leu 280 Cys Arg Arg Ser Ala 360 Cys Leu Leu Glu Ser 440 Ile Asn Ile 185 Asp Lys Ser Thr Ser 265 Leu Leu Trp Val1 Val1 345 Cys Arg Thr Asn Phe 425 Ile Ser Ile 170 Ser Pro Leu Ile Phe 250 Val Leu Ile Cys Lys 330 Pro Leu Tyr Val1 Ile 410 Asp Gin Ile Ser Phe Val Tyr Val1 235 Ser Ser Lys Leu Ala 315 Thr Asp Arg Lys Ile 395 Lys Ile Thr Asp Thr 475 Ala Thr Thr 220 Met Ser Leu His Leu 300 Val1 Ile Arg Gly Phe 380 Ile Thr Glu Asp Gin 460 Thr Asp Ile 205 Ile Phe Val1 Leu Thr 285 Ile Phe Arg Ile Ala 365 Thr Phe Gly Ala Leu 445 Phe Gin Ala 190 Leu Ile Glu Phe Ile 270 His Ile Pro Ser Pro 350 Val1 Leu Gly Cys Pro 430 Cys Ala Gly 175 Met Ser Phe Thr Glu 255 Gly Ile Val1 Leu Met 335 Tyr Gly Leu Gly Ile 415 Arg Pro Val1 Asn Ser Ile Cy Cys 240 Cys Val1 Arg Ala Ser 320 Ser Asn Val1 Ala Thr 400 Ser Ala Tyr Ser Thr 480 Phe Cys Cys Leu Asn Glu Thr Glu Asn Thr Ser Pro Asn Pro Ala Arg 485 490 495 Ser Ser Asn Asn Ser Asp 515 Asp Lys Arg Asn 500 Ser Gin Trp Phe 41g Leu Arg Asp Lys Leu 505 Gly Thr Ile Phe 510 Gin Val Leu 525 Gin 520 Asn Phe Asp Giu <210> 4 <211> 11 <212> PRT <213> Homo sapiens <400> 4 Asp Vai Phe Phe Leu Phe Leu Leu Pro Pro Ile 1 5 <210> <211> 38 <212> DNA <213> Arabidopsis thaiiana <400> ggcccgggat ggattctcta gtgtcgaaac tgccttcg

Claims (80)

1. A drought and freeze resistant transgenic plant comprising a polynucleotide sequence comprising a exogenous tonoplast pyrophosphate driven H+ pump gene operably linked to a promoter. s 2. A transgenic seed produced by the drought and freeze resistant transgenic plant of Claim 1.

3. A progeny plant from the transgenic seed of Claim 2.

4. A drought and freeze resistant transgenic plant containing a polynucleotide sequence comprising a exogenous tonoplast pyrophosphate driven H+ pump gene .o0 operably linked to a double tandem enhancer of the 35S promoter. A transgenic plant containing a polynucleotide sequence comprising a multiplicity of exogenous tonoplast pyrophosphate driven H+ pump genes operably linked to a double tandem enhancer of the 35S promoter, wherein the number of pyrophosphate driven H+ pump genes is sufficient to express a sufficient number of pyrophosphate driven H+ pumps on the vacuolar membranes to produce drought and freeze resistance as compared to wild-type plants.

6. A transgenic plant which is tolerant to a salt, comprising one or more plant cells transformed with exogenous nucleic acid which increases expression of vacuolar pyrophosphatase (AVP in the plant.

7. The transgenic plant of Claim 6 wherein the exogenous nucleic acid encodes AVP1.

8. The transgenic plant of Claim 6 wherein the exogenous nucleic acid encodes a homologue of AVP 1.

9. The transgenic plant of Claim 8 wherein the homologue of AVP1 is tobacco, bacteria, tomato or corn AVPI. The transgenic plant of Claim 7 wherein the AVPI is present in a construct designed to overexpress AVP1 or endogenous pyrophosphatase.

11. The transgenic plant of Claim 10 wherein the construct comprises the AVP1 gene operably linked to a double tandem enhancer of a 35S promoter. 30 12. The transgenic plant of any one of Claims 7, 10 or 11 wherein the AVP1 gene is derived from a wild type plant that corresponds to a wild type of the transgenic plant.

13. The transgenic plant of any one of Claims 7, 10 or 11 wherein the AVP1 gene is derived from a wild type plant that does not correspond to a wild type of the 35 transgenic plant.

14. A transgenic plant according to any one of claims 6 to 13 which grows in a concentration of a salt that inhibits growth of a corresponding non-transgenic plant.

15. The transgenic plant of Claim 14 wherein the concentration of salt is about S* 0.2M to about 0.3M. 40 16. The transgenic plant of any one of Claims 7, 10, 11, 12 or 13 wherein the plant is larger than a corresponding non-transgenic plant. A595871speci

17. A transgenic progeny of the transgenic plant of any one of Claims 6 to 16.

18. Transgenic seeds produced by the transgenic plant of any one of Claims 6 to 16.

19. A progeny transgenic plant grown from the transgenic seed of Claim 18.

20. A transgenic plant which is tolerant to a salt comprising an exogenous nucleic acid construct which is designed to overexpresses AVP1 or endogenous pyrophosphatase.

21. A transgenic progeny of the transgenic plant of Claim

22. Transgenic seeds produced by the transgenic plant of Claim to 23. A progeny transgenic plant grown from the transgenic seed of Claim 22.

24. The transgenic plant of Claim 10 wherein the construct comprises an AVP1 gene operably linked to a double tandem enhancer of a 35S promoter. A transgenic plant obtained by introducing into a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant.

26. Plant cells comprising exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant cell.

27. The plant cells of Claim 26 wherein the plant cells are root cells or stem cells.

28. The plant cells of Claim 26 or Claim 27 wherein the exogenous nucleic acid encodes AVP1.

29. The plant cells of Claim 28 wherein the AVP1 gene is present in a construct designed to overexpress AVP1 or endogenous pyrophosphatase. The plant cells of Claim 29 wherein the construct comprises the AVP1 gene operably linked to a chimeric promoter designed to overexpress AVP1.

31. The plant cells of Claim 30 wherein the AVP1 gene is operably linked to a double tandem enhancer of a 35S promoter.

32. The plant cells of any one of Claims 28 to 31 wherein the AVP1 gene is 0derived from a wild type plant that corresponds to a wild type of the transgenic plant.

33. The plant cells of any one of Claims 28 to 31 wherein the AVP1 gene is 30 derived from a wild type plant that does not correspond to a wild type of the transgenic plant.

34. A method of making a transgenic plant which is tolerant to a salt comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells *0 s35 in the plant, thereby producing a transgenic plant which is tolerant to the salt.

35. The method of Claim 34 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is tolerant to the salt, thereby producing a transgenic plant which is tolerant to the salt.

36. The method of Claim 34 or Claim 35 wherein the exogenous nucleic acid 40 encodes AVP1.

37. The method of Claim 36 wherein the AVP1 gene is present in a construct designed to overexpress AVP1 or endogenous pyrophosphatase. AS95871spcci 44

38. The method of Claim 37 wherein the construct comprises the AVP1 gene operably linked to a chimeric promoter designed to overexpress AVP1.

39. The method of Claim 38 wherein the AVP1 gene is operably linked to a double tandem enhancer of a 35S promoter.

40. The method of any one of Claims 36 to 39 wherein the AVP1 gene is derived from a wild type plant that corresponds to a wild type of the transgenic plant.

41. The method of any one of Claims 36 to 39 wherein the AVP1 gene is derived from a wild type plant that does not correspond to a wild type of the transgenic plant.

42. The method of any one of Claims 34 to 41 wherein the plant is tolerant to a concentration of salt that inhibits growth of a corresponding non-transgenic plant.

43. The method of Claim 42 wherein the concentration of salt is about 0.2M to about 0.3M.

44. A transgenic plant produced by the method of any one of Claims 34 to 43. Is 45. A method of making a transgenic plant which is tolerant to a salt comprising introducing into one or more cells of a plant a nucleic acid construct which is designed to overexpress AVP1 to yield transformed cells thereby producing a transgenic plant which is tolerant to the salt.

46. The method of Claim 45 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is tolerant to the salt, thereby producing a transgenic plant which is tolerant to the salt.

47. A transgenic plant produced by the method of Claim 45 or Claim 46.

48. A method of making a transgenic plant which is larger than its corresponding wild type plant comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant which is larger than its corresponding wild type plant.

49. The method of Claim 48 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is 30 larger than its corresponding wild type plant, thereby producing a transgenic plant which is larger than its corresponding wild type plant. The method of Claim 48 or Claim 49 wherein the exogenous nucleic acid encodes AVP1.

51. The method of Claim 50 wherein the AVP1 gene is present in a construct 35 designed to overexpress AVP1 or endogenous pyrophosphatase.

52. The method of Claim 51 wherein the construct comprises the AVP1 gene operably linked to a chimeric promoter designed to overexpress AVP1.

53. The method of Claim 52 wherein the AVP1 gene is operably linked to a double tandem enhancer of a 35S promoter. 40 54. The method of any one of Claims 50 to 53 wherein the AVP1 gene is derived from a wild type plant that corresponds to a wild type of the transgenic plant. A595871speci The method of any one of Claims 50 to 54 wherein the AVP1 gene is derived from a wild type plant that does not correspond to a wild type of the transgenic plant.

56. The method of any one of Claims 48 to 55 wherein the transgenic plant is grown in soil.

57. The method of any one of Claims 48 to 55 wherein the transgenic plant is grown hydroponically.

58. A transgenic plant produced by the method of any one of Claims 48 to 57.

59. A method of bioremediating soil comprising growing one or more transgenic plants and/or progeny thereof in the soil, wherein the transgenic plants and/or progeny thereof comprise exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant. A method of increasing the yield of a plant comprising introducing into one or more cells of a plant nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby increasing the yield of the plant.

61. The method of Claim 60 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is larger than its corresponding wild type plant, thereby increasing the yield of the plant.

62. A method of removing cations from a medium which can support plant growth comprising growing one or more transgenic plants and/or progeny thereof in the medium, wherein the transgenic plants and/or progeny thereof comprise exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant.

63. The method of Claim 62 wherein the medium is selected from the group consisting of: soil and water.

64. The method of Claim 62 or Claim 63 wherein the cations are selected from the group consisting of: sodium, calcium, manganese and lead.

65. A method of producing a transgenic plant which grows in salt water comprising introducing into one or more cells of a plant exogenous nucleic acid which 30 increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant which can grow in salt water.

66. The method of Claim 65 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which grow in salt water, thereby producing a transgenic plant which can grow in salt water. 35 67. The method of Claim 65 or Claim 66 wherein the concentration of the salt water is from about 0.2M to about 0.3M. *68. The method of Claim 67 wherein the salt water is seawater.

69. A transgenic plant which is tolerant to a salt, comprising one or more plant cells transformed with exogenous nucleic acid which increases expression of a vacuolar pyrophosphatase. The transgenic plant of Claim 69 wherein the vacuolar pyrophosphatase is AVP 1 or a homologue thereof. A595871speci

71. The transgenic plant of Claim 70 wherein the homologue of AVP1 is tobacco, bacteria, tomato or corn AVP1.

72. The transgenic plant of Claim 70 wherein the gene encoding AVP1 or a homologue thereof is present in a construct designed to overexpress AVP1 or a homologue thereof or endogenous pyrophosphatase.

73. The transgenic plant of Claim 72 wherein the construct comprises the AVP1 gene operably linked to a double tandem enhancer of a 35S promoter.

74. A transgenic progeny of the transgenic plant of any one of Claims 69 to 73. 0o 75. Transgenic seeds produced by the transgenic plant of any one of Claims 69 to 73.

76. A progeny transgenic plant grown from the transgenic seed of Claim

77. A method of making a transgenic plant having increased flower size compared to its corresponding wild type plant comprising introducing into one or more cells of a plant exogenous nucleic acid which increases expression of vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant having increased flower size compared to its corresponding wild type plant.

78. The method of Claim 77 wherein the exogenous nucleic acid encodes AVP1.

79. A transgenic plant produced by the method of Claim 77 or Claim 78. A transgenic plant comprising a polynucleotide sequence comprising at least one exogenous tonoplast pyrophosphate driven H+ pump gene operably linked to a promoter, said plant being substantially as hereinbefore described with reference to any one of examples 6 to 9.

81. A transgenic plant which is tolerant to a salt, comprising one or more plant cells transformed with exogenous nucleic acid which alters expression of vacuolar pyrophosphatase in the plant, said plant being substantially as hereinbefore described with ,reference to any one of examples 6 to 9.

82. A transgenic plant which grows in a concentration of a salt that inhibits S 30 growth of a corresponding non-transgenic plant, said plant being substantially as hereinbefore described with reference to any one of examples 6 to 9.

83. A transgenic plant obtained by introducing into a plant exogenous nucleic acid which alters expression of vacuolar pyrophosphatase in the plant, said plant being substantially as hereinbefore described with reference to any one of examples 6 to 9.

84. A method of making a transgenic plant which is tolerant to a salt, said method being substantially as hereinbefore described with reference to any one of examples 6 to

85. A method of making a transgenic plant which is larger than its corresponding wild type plant, said method being substantially as hereinbefore described 40 with reference to examples 7 or 8. A595871speci 47

86. A method of increasing the yield of a plant compared to the wild-type plant, said method being substantially as hereinbefore described with reference to examples 7 or 8.

87. A method of removing cations from a medium which can support plant growth comprising growing one or more transgenic plants as described in claim 1 and/or progeny thereof in the medium, said method being substantially as hereinbefore described with reference to examples 9 or

88. A method of producing a transgenic plant which grows in salt water, said method being substantially as hereinbefore described with reference to example 8.

89. or 88. A transgenic plant produced by the method of any one of Claims 65 to 68 S S S S S 0@ 9* A transgenic plant produced by the method of any one of Claims 84 to 87.

91. A transgenic plant comprising a plurality of plant cells according to any one of claims 26 to 33. is 92. A transgenic progeny of the transgenic plant of any one of Claims 79 to 83.

93. A transgenic progeny of the transgenic plant of any one of Claims 44, 47, 58 or 79.

94. A transgenic progeny of the transgenic plant of any one of Claims 89 to 91. Transgenic seed produced by the transgenic plant of any one of Claims to 83.

96. Transgenic seed produced by the transgenic plant of any one of Claims 44, 47, 58 or 79. 25 97. Transgenic seed produced by the transgenic plant of any one of Claims 89 to 91.

98. A progeny transgenic plant grown from seed of any one of Claims 95 to 97.

99. A transgenic plant with increased yield compared to the wild-type plant produced by the method of Claim 60 or Claim 61.

100. A transgenic progeny of the transgenic plant of Claim 99.

101. Transgenic seed produced by the transgenic plant of Claim 99.

102. A progeny transgenic plant grown from seed of Claim 101. Dated 21 March, 2005 University of Connecticut Whitehead Institute for Biomedical Research Beth Israel Deaconess Medical Center, Inc. Patent Attorneys for the Applicant/Nominated Person SPRUSON FERGUSON A595871speci